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C39H54N2O2 
 
(2S)-[N,N’- bis-(2’-hydroxy-3’,5’-di-tert-butyl benzylidene)]-3-phenyl-1,2-diaminopropane 
 
 
[α]D
20 +63.5 (c 0.052, CHCl3) 
Prepared from (S)-phenylalanine 
 
Yuri N. Belokon', Jamie Hunt and Michael North 
 
N N
Me
OH HO
tBu
tBu
tBu
tBu
 
 
C33H50N2O2 
 
(2S)-[N,N’-bis-(2’-hydroxy-3’,5’-di-tert-butyl benzylidene)]-1,2-diaminopropane 
 
 
[α]D
20 +173.0 (c 0.1, CHCl3) 
Prepared from (S)-alanine 
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C38H53N2O2 
 
(1R)-[N,N’-bis-(2’-hydroxy-3’,5’-di-tert-butyl benzylidene)]- 1-phenyl-1,2-diaminoethane 
 
 
[α]D
20 -27.2 (c 0.25, CHCl3) 
Prepared from (R)-phenylglycine 
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C35H54N2O2 
 
(2S)-[N,N’-bis-(2’-hydroxy-3’,5’-di-tert-butyl benzylidene)]-3-methyl-1,2-diaminobutane 
 
 
[α]D
20 +84.0 (c 0.1, CHCl3) 
Prepared from (S)-valine 
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C19H22N2O4 
 
(2S)-[N,N’-bis-(2’-hydroxy-4’-methoxy benzylidene)]-1,2-diaminopropane 
 
 
[α]D
20 +425.0 (c 0.04, CHCl3) 
Prepared from (S)-alanine 
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C25H26N2O4 
 
(2S)-[N,N’- bis-(2’-hydroxy-4’-methoxy benzylidene)]-3-phenyl-1,2-diaminopropane 
 
 
[α]D
20 +67.0 (c 0.06, CHCl3) 
Prepared from (S)-phenylalanine 
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C24H24N2O4 
 
(1R)-[N,N’-bis-(2’-hydroxy-4’-methoxy benzylidene)]-1-phenyl-1,2-diaminoethane 
 
 
[α]D
20 -60.0 (c 0.06, CHCl3) 
Prepared from (R)-phenylglycine 
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C21H26N2O4 
 
(2S)-[N,N’-bis-(2’-hydroxy-4’-methoxy benzylidene)]-3-methyl-1,2-diaminobutane 
 
 
[α]D
20 +78.6 (c 0.5, CHCl3) 
Prepared from (S)-valine 
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C17H18N2O2 
 
(2S)-[N,N’-bis-(2’-hydroxybenzylidene)]-1,2-diaminopropane 
 
 
[α]D
20 +332.0 (c 0.05, CHCl3) 
Prepared from (S)-alanine 
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C23H22N2O2 
 
(2S)-[N,N’- bis-(2’-hydroxybenzylidene)]-3-phenyl-1,2-diaminopropane 
 
 
[α]D
20 +88.0 (c 0.05, CHCl3) 
Prepared from (S)-phenylalanine 
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C19H22N2O2 
 
(2S)-[N,N’-bis-(2’-hydroxybenzylidene)]-3-methyl-1,2-diaminobutane 
 
 
[α]D
20 +250.0 (c 0.03, CHCl3) 
Prepared from (S)-valine 
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C33H48N2O2TiCl2 
 
[(2S)-[N,N’-bis-(2’-hydroxy-3’,5’-di-tert-butyl benzylidene)]-1,2-diaminopropanato] titaniumIV chloride 
 
 
[α]D
20 +800.0 (c 0.003, CHCl3) 
Prepared from (S)-alanine 
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C39H52N2O2TiCl2 
 
[(2S)-[N,N’- bis-(2’-hydroxy-3’,5’-di-tert-butyl benzylidene)]-3-phenyl-1,2-diaminopropanato] titaniumIV chloride 
 
 
[α]D
20 -266.7 (c 0.006, CHCl3) 
Prepared from (S)-phenylalanine 
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C38H50N2O2TiCl2 
 
[(1R)-[N,N’-bis-(2’-hydroxy-3’,5’-di-tert-butyl benzylidene)]- 1-phenyl-1,2-diaminoethanato] titaniumIV chloride 
 
 
[α]D
20 +1300.0 (c 0.004, CHCl3) 
Prepared from (R)-phenylglycine 
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C35H52N2O2TiCl2 
 
[(2S)-[N,N’-bis-(2’-hydroxy-3’,5’-di-tert-butyl benzylidene)]-3-methyl-1,2-diaminobutanato] titaniumIV chloride 
 
 
[α]D
20 -240.0 (c 0.005, CHCl3) 
Prepared from (S)-valine 
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C33H48N2O3VCl 
 
[(2S)-[N,N’-bis-(2’-hydroxy-3’,5’-di-tert-butyl benzylidene)]-1,2-diaminopropanato] vanadiumV chloride 
 
 
[α]D
20 +1050.0 (c 0.002, CHCl3) 
Prepared from (S)-alanine 
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C39H52N2O3VCl 
 
[(2S)-[N,N’- bis-(2’-hydroxy-3’,5’-di-tert-butyl benzylidene)]-3-phenyl-1,2-diaminopropanato] vanadiumV chloride 
 
 
[α]D
20 -690.0 (c 0.02, CHCl3) 
Prepared from (S)-phenylalanine 
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C38H50N2O3VCl 
 
[(1R)-[N,N’-bis-(2’-hydroxy-3’,5’-di-tert-butyl benzylidene)]-1-phenyl-1,2-diaminoethanato] vanadiumV chloride 
 
 
[α]D
20 +320.0 (c 0.02, CHCl3) 
Prepared from (R)-phenylglycine 
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C35H52N2O3VCl 
 
[(2S)-[N,N’-bis-(2’-hydroxy-3’,5’-di-tert-butyl benzylidene)]-3-methyl-1,2-diaminobutanato] vanadiumV chloride 
 
 
[α]D
20 -3600.0 (c 0.0033, CHCl3) 
Prepared from (S)-valine 
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C17H16N2O2Cu 
 
[(2S)-[N,N’-bis-(2’-hydroxybenzylidene)]-1,2-diaminopropanato] copperII 
 
 
[α]D
20 -140.0 (c 0.02, CHCl3) 
Prepared from (S)-alanine 
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C23H20N2O2Cu 
 
[(2S)-[N,N’-bis-(2’-hydroxybenzylidene)]-3-phenyl-1,2-diaminopropanato] copperII 
 
 
[α]D
20 -320.0 (c 0.01, CHCl3) 
Prepared from (S)-phenylalanine 
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C22H18N2O2Cu 
 
[(2S)-[N,N’-bis-(2’-hydroxybenzylidene)]-2-phenyl-1,2-diaminoethanato] copperII 
 
 
[α]D
20 -400.0 (c 0.01, CHCl3) 
Prepared from (R)-phenylglycine 
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[(2S)-[N,N’-bis-(2’-hydroxybenzylidene)]-2-phenyl-1,2-diaminoethane 
 
 
[α]D
20 +88.0 (c 0.05, CHCl3) 
Prepared from (R)-phenylglycine 
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[(2S)-[N,N’-bis-(2’-hydroxybenzylidene)]-3-phenyl-1,2-diaminopropanato] cobaltII 
 
 
[α]D
20 -720.0 (c 0.01, CHCl3). 
Prepared from (S)-phenylalanine 
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[(2S)-[N,N’-bis-(2’-hydroxybenzylidene)]-2-phenyl-1,2-diaminoethanato] cobaltII 
 
 
[α]D
20 +640.0 (c 0.01, CHCl3) 
Prepared from (R)-phenylglycine 
 
 
Yuri N. Belokon', Jamie Hunt and Michael North 
 
N N
Me
O O
Co
 
 
C17H16N2O2Co 
 
[(2S)-[N,N’-bis-(2’-hydroxybenzylidene)]-1,2-diaminopropanato] cobaltII 
 
 
[α]D
20 -1180.0 (c 0.02, CHCl3) 
Prepared from (S)-alanine 
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C19H22N2O2Cu 
 
[(2S)-[N,N’-bis-(2’-hydroxybenzylidene)]-3-methyl-1,2-diaminobutanato] copperII 
 
 
[α]D
20 -160.0 (c 0.01, CHCl3) 
Prepared from (S)-valine 
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C19H20N2O4Co 
 
[(2S)-[N,N’-bis-(2’-hydroxy-4’-methoxybenzylidene)]-1,2-diaminopropanato] cobaltII 
 
 
[α]D
20 -560.0 (c 0.01, CHCl3) 
Prepared from (S)-alanine 
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C25H24N2O4Co 
 
[(2S)-[N,N’-bis-(2’-hydroxy-4’-methoxybenzylidene)]-3-phenyl-1,2-diaminopropanato] cobaltII 
 
 
[α]D
20 -1500.0 (c 0.02, CHCl3) 
Prepared from (S)-phenylalanine 
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[(1R)-[N,N’-bis-(2’-hydroxy-4’-methoxybenzylidene)]-1-phenyl-1,2-diaminoethanato] cobaltII 
 
 
[α]D
20 +440.0 (c 0.01, CHCl3) 
Prepared from (R)-phenylglycine 
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[(2S)-[N,N’-bis-(2’-hydroxybenzylidene)]-3-methyl-1,2-diaminobutanato] cobaltII 
 
 
[α]D
20 -707.7 (c 0.013, CHCl3) 
Prepared from (S)-valine 
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C11H15NOSi 
 
(R)-Phenyl-trimethylsilanoxy-acetonitrile 
 
 
Enantiomeric excess 20-30% determined by chiral GC 
Absolute configuration determined by order of elution from a chiral 
GC column 
Prepared using asymmetric catalysts 
 
Yuri N. Belokon', Jamie Hunt and Michael North 
 
OSiMe3
CN
 
 
C11H15NOSi 
 
(S)-Phenyl-trimethylsilanoxy-acetonitrile 
 
 
Enantiomeric excess 4-81% determined by chiral GC 
Absolute configuration determined by order of elution from a chiral 
GC column 
Prepared using asymmetric catalysts 
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C12H17NOSi 
 
(S)-(2-Methylphenyl)-trimethylsilanoxy-acetonitrile 
 
 
Enantiomeric excess 66% determined by chiral GC 
Absolute configuration determined by order of elution from a chiral 
GC column 
Prepared using an asymmetric catalyst 
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[(2S)-[N,N’-bis-(2’-hydroxy-4’-methoxybenzylidene)]-3-methyl-1,2-diaminobutanato] cobaltII 
 
 
[α]D
20 -160.0 (c 0.01, CHCl3) 
Prepared from (S)-valine 
 
 
  
 
Yuri N. Belokon', Jamie Hunt and Michael North 
 
OSiMe3
CN
Me
 
 
C12H17NOSi 
 
(S)-(4-Methylphenyl)-trimethylsilanoxy-acetonitrile 
 
 
Enantiomeric excess 78% determined by chiral GC 
Absolute configuration determined by order of elution from a chiral 
GC column 
Prepared using an asymmetric catalyst 
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(S)-(3-Methoxyphenyl)-trimethylsilanoxy-acetonitrile 
 
 
Enantiomeric excess 66% determined by chiral GC 
Absolute configuration determined by order of elution from a chiral 
GC column 
Prepared using an asymmetric catalyst 
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C12H17NO2Si 
 
(S)-(4-Methoxyphenyl)-trimethylsilanoxy-acetonitrile 
 
 
Enantiomeric excess 45% determined by chiral GC 
Absolute configuration determined by order of elution from a chiral 
GC column 
Prepared using an asymmetric catalyst 
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C12H17NOSi 
 
(S)-(3-Methylphenyl)-trimethylsilanoxy-acetonitrile 
 
 
Enantiomeric excess 81% determined by chiral GC 
Absolute configuration determined by order of elution from a chiral 
GC column 
Prepared using an asymmetric catalyst 
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C8H17NOSi 
 
(S)-2-Trimethylsilanoxy-3-methyl-butanonitrile 
 
 
Enantiomeric excess 73% determined by chiral GC 
Absolute configuration determined by order of elution from a chiral 
GC column 
Prepared using an asymmetric catalyst 
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C13H27NOSi 
 
(S)-2-Trimethylsilanoxy-deconitrile 
 
 
Enantiomeric excess 73% determined by chiral GC 
Absolute configuration determined by order of elution from a chiral 
GC column 
Prepared using an asymmetric catalyst 
Yuri N. Belokon', Jamie Hunt and Michael North 
 
OSiMe3
CN
 
 
C11H21NOSi 
 
(S)-Cyclohexyl-trimethylsilanoxy-acetonitrile 
 
 
Enantiomeric excess 73% determined by chiral GC 
Absolute configuration determined by order of elution from a chiral 
GC column 
Prepared using an asymmetric catalyst 
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C12H14NO4F3Si 
 
(S)-(4-Trifluoromethylphenyl)-trimethylsilanoxy-acetonitrile 
 
 
Enantiomeric excess 77% determined by chiral GC 
Absolute configuration determined by order of elution from a chiral 
GC column 
Prepared using an asymmetric catalyst 
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C11H15N2O2 
 
(S)--methyl-phenylalanine methyl ester 
 
 
Enantiomeric excess 0-29% determined by 1H NMR analysis of the 
diastereomeric ureases formed by reaction with (S)-1-phenylethyl 
isocyanate. 
Absolute configuration determined from the known NMR spectra of 
the diastereomeric ureas. 
Prepared using an asymmetric catalyst 
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C15H14N 
 
N-benzyl (R)-2-aminoacetonitrile 
 
 
Enantiomeric excess 9% determined by 1H NMR analysis in the 
presence of (R)-camphor sulphonic acid. 
Absolute configuration determined from the known NMR spectra of 
the diastereomeric camphor sulphonate salts. 
Prepared using asymmetric catalysts 
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C15H14N 
 
N-benzyl (S)-2-aminoacetonitrile 
 
 
Enantiomeric excess 10-90% determined by 1H NMR analysis in the 
presence of (R)-camphor sulphonic acid. 
Absolute configuration determined from the known NMR spectra of 
the diastereomeric camphor sulphonate salts. 
Prepared using asymmetric catalysts 
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C9H19NOSi 
 
(S)-2-Trimethylsilanoxy-3,3-dimethyl-butanonitrile 
 
 
Enantiomeric excess 45% determined by chiral GC 
Absolute configuration determined by order of elution from a chiral 
GC column 
Prepared using an asymmetric catalyst 
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C21H17NO2 
 
N,N-Diphenyl (2S,3R)-3-phenyl-oxirane-2-carboxamide 
 
 
Enantiomeric excess 0-21% determined by chiral HPLC. 
Absolute configuration determined from the known HPLC retention 
times. 
Prepared using asymmetric catalysts 
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C21H17NO2 
 
N,N-Diphenyl (2S,3S)-3-phenyl-oxirane-2-carboxamide 
 
 
Enantiomeric excess 0-18% determined by chiral HPLC. 
Absolute configuration determined from the known HPLC retention 
times. 
Prepared using asymmetric catalysts 
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 Asymmetric catalysis of carbon-carbon bond forming reactions 
using amino acid derived C1-symmetrical salen ligands 
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b
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Abstract—Four amino acids (alanine, valine, phenylalanine and phenylglycine) have been converted into C1-symmetrical salen ligands 
and complexed to titanium, vanadium, copper and cobalt. The resulting complexes have been used as asymmetric catalysts for asymmetric 
cyanohydrin synthesis, asymmetric Strecker reactions, asymmetric synthesis of -methyl amino acids and asymmetric Darzens 
condensations. Satisfactory levels of asymmetric induction were obtained from reactions in which the (salen)metal complex acts as a chiral 
Lewis acid, but low levels of asymmetric induction were obtained from reactions carried out under solid-liquid phase transfer conditions.  
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1. Introduction 
 Over the last twelve years,
1
 we have developed 
metal(salen) complexes derived from cyclohexanediamine 
as highly effective catalysts for a range of carbon-carbon 
bond forming reactions. Titanium
IV
 1 and vanadium
V
 2a,b 
complexes were found to catalyze the asymmetric addition 
of trimethylsilyl cyanide,
1,2
 metal cyanides
1,3
 (in the 
presence of an anhydride) and cyanoformates
1,4
 to 
aldehydes (Scheme 1). Complexes 1 and 2 are active at 
room temperature with a substrate to catalyst ratio of up to 
1000:1. These complexes also afford products with ee’s 
>90% from a wide range of aromatic aldehydes. Aliphatic 
aldehydes are also acceptable substrates, although with 
reduced enantioselectivities (70-90%) and complex 1 will 
also catalyze the asymmetric addition of trimethylsilyl 
cyanide to ketones,
1,5
 whilst complex 2a will catalyze the 
asymmetric addition of trimethylsilyl cyanide to imines.
6
 
Complexes 1 and 2 have been commercialized
7
 by NPIL 
under the trademark CACHy. 
 Whilst titanium and vanadium(salen) complexes were 
found to form effective Lewis acid based catalysts, copper
II
 
and cobalt
II
(salen) complexes 3a,b and 4 were found to 
function as asymmetric phase transfer catalysts.
1,8
 Thus 
complexes 3a,b were found to catalyze the asymmetric 
alkylation of amino ester enolates, leading to the 
asymmetric synthesis of -disubstituted amino acids 
(Scheme 2).
9
 In a preliminary study,
10
 complex 4 was found 
to catalyze asymmetric Darzens condensations as shown in 
Scheme 3. 
 Catalysts 1-4 all possess C2-symmetry. Whilst C2-
symmetrical catalysts are often useful in reducing the 
number of possible transition states for a reaction,
11
 C2-
symmetry is not always advantageous in an asymmetric 
catalyst since it restricts the options for optimizing the 
chiral environment around the catalyst.
12
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Scheme 1. Asymmetric cyanohydrin synthesis using complexes 1 and 2. 
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 We have previously reported the use of C1-symmetrical 
salen derived catalysts related to complexes 1-4 in 
asymmetric cyanohydrin synthesis
13
 and asymmetric 
enolate alkylation.
9a,c
 In this manuscript we give full details 
of our recent work in this area,
14
 focussing on the use of 
amino acid derived salen ligands bearing unfunctionalized 
sidechains as catalysts for asymmetric cyanohydrin 
synthesis, asymmetric Strecker reactions, asymmetric 
amino acid synthesis and asymmetric Darzens 
condensations.  
3a: R = H; M = Cu
3b: R = H; M = Co
4: R = OMe; M = Co
NN
O O
Co
R R
 
R
CO2R'NAr
NaOH (solid) /
3a,b (cat) /
R"X
R
CO2R'NAr
R"
R
CO2HH2N
R"
 
Scheme 2. Asymmetric amino acid synthesis using complexes 3a,b. 
RCHO  + XCH2CONPh2
O
R
NPh2
O
+
O
R
NPh2
O
MOH (solid) 
/ 4 ( cat)
X = Cl, Br, I
M = Na, K, Rb
 
Scheme 3. Asymmetric Darzens condensations using complex 4. 
2. Results and discussion 
2.1. Synthesis of catalysts 
 The amino acids (S)-alanine, (S)-phenylalanine, (R)-
phenylglycine and (S)-valine were selected as chiral 
starting materials for the synthesis of the salen ligands on 
the basis of the different steric environments associated 
with their unfunctionalized sidechains. The synthesis of the 
C1-symmetrical salen ligands was achieved as outlined in 
Scheme 4. Amino acid methyl ester hydrochlorides 5a-d 
were each converted into the corresponding amino amides 
6a-d by treatment with a saturated solution of ammonia in 
methanol.
15
 The resulting amino amides were then reduced 
by lithium aluminium hydride in refluxing THF to give 
diamines 7a-d.
16
 Diamines 7a,c,d were purified at this 
stage by formation and precipitation of the corresponding 
dihydrochloride salts. This procedure was not effective for 
diamine 7b, therefore it was used as the free diamine. 
NH3 / 
MeOH
N
N
ROH
OH
tBu
tBu
tBu
tBu
N
N
ROH
OH
R'
R'
8a-d
9a-d; R' = OMe
10a-d; R' = H
4-methoxy-salicylaldehyde
or salicylaldehyde /
, 20-48 hours
R
CO2MeHCl. H2N
R
CONH2H2N
LiAlH4 / THF
R
H2N
NH2
5a-d 6a-d
7a-d
a: R = Me; stereochemistry = S
b: R = CH2Ph; stereochemistry = S
c: R = Ph; stereochemistry = R
d: R = CHMe2; stereochemistry = S
3,5-di-tert-butyl
salicylaldehyde /
, 20-48 hours
(58-90%)
(48-100%)
 
Scheme 4. Synthesis of ligands 8a-d, 9a-d and 10a-d. 
 Diamines 7a-d were converted into salen ligands 8a-d, 
9a-d and 10a-d by condensation with the appropriate 
salicylaldehyde derivative.
17,18
 In the case of diamine 7b 
which was isolated as the free amine, this was achieved by 
refluxing a mixture of diamine and two equivalents of 
aldehyde in ethanol for 20 hours. Shorter reaction times 
resulted in formation of variable amounts of the mono-
imine where only the less hindered of the two amino groups 
had reacted. Salen ligand formation from diamines 7a,c,d, 
which were isolated as their hydrochloride salt, was 
achieved using a mixed solvent system of methanol and 
ethanol to dissolve the hydrochloride salt in the presence of 
sodium methoxide. For reactions involving diamines 7a,c, a 
reaction time of 24 hours was sufficient to obtain salen 
ligands 8a,c, 9a,c and 10a,c, but the more sterically 
hindered diamine 7d required a reaction time of 48 hours at 
reflux to form ligands 8-10d. 
 Ligands 8a-d were used to prepare both titanium
IV
 and 
vanadium
V
 complexes. Treatment of ligands 8a-d with 
titanium
IV
 chloride gave complexes 11a-d in a quantitative 
yield (Scheme 5). All attempts to convert complexes 11a-d 
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into the corresponding bis--oxo bridged bimetallic 
complexes analogous to complex 1 were unsuccessful and 
resulted in decomposition back to ligands 8a-d and/or 
diamines 7a-d. In light of this, complexes 11a-d were used 
as precatalysts for asymmetric cyanohydrin synthesis since 
it is known that related C2-symmetrical complexes 
hydrolyze to the bimetallic complexes in situ.
2a,19
 
N N
R
OH HO
tBu
tBu
tBu
tBu
8a-d
N N
R
O O
tBu
tBu
tBu
tBu
Ti
Cl
Cl
11a-d
TiCl4 / CH2Cl2
N N
R
O O
tBu
tBu
tBu
tBu
V
O
Cl
1) VOSO4, EtOH, 
2) (NH4)2Ce(NO3)6
3) HCl (aq.)
or VOCl3
12a-d
(100%)
(50-90%)
 
Scheme 5. Synthesis of titaniumIV complexes 11a-d and vanadiumV 
complexes 12a-d. 
 Two routes were developed for the synthesis of 
vanadium
V
 complexes 12a-d of ligands 8a-d. For 
asymmetric cyanohydrin synthesis it was important that the 
complex possess a chloride ligand, as we have recently 
shown that the nature of the counterion / sixth ligand has a 
major effect on the rate of catalysis, though not on the 
enantioselectivity.
2d
 Thus, complex 2b is more reactive 
than complex 2a. Complexes 12a-c were prepared by a two 
step synthesis in which ligands 8a-c were first treated with 
vanadyl sulphate to give a mixture of vanadium
IV
 and 
vanadium
V
(salen) complexes (Scheme 5). Treatment of this 
mixture with ceric ammonium nitrate followed by 
hydrochloric acid accomplished complete oxidation and 
counterion exchange to form complexes 12a-c.
20
 For the 
synthesis of complex 12d however, a more direct route 
involving treatment of ligand 10d with vanadium
V
 
oxychloride was found to be effective. 
 Both copper
II
 and cobalt
II
(salen) complexes form 
effective asymmetric phase transfer catalysts. For the 
asymmetric alkylation of amino ester enolates,
1,8
 both 
metals are equally effective and the optimal ligand contains 
unsubstituted aromatic rings. In contrast, for the 
asymmetric Darzens condensation only cobalt
II
 complexes 
were found to be catalytically active and the optimal ligand 
structure contains methoxy substituents.
10
 Therefore, 
ligands 10a-d were complexed to both copper and cobalt 
(Scheme 6) to give complexes 13a-d and 14a-d 
respectively and ligands 9a-d were complexed to cobalt to 
give complexes 15a-d. The copper complexes were 
prepared from copper acetate in an ethanol and water 
solvent system. The preparation of the cobalt complexes 
was also achieved from the metal acetate, but required 
anhydrous reaction conditions and an inert atmosphere to 
avoid oxidation to the corresponding cobalt
III
 complexes. In 
most cases, the cobalt complexes were conveniently formed 
in ethanolic solution, but complex 14d had to be formed in 
tetrahydrofuran due to the lack of solubility of ligand 10d. 
N N
R
O O
Cu
13a-d
N N
R
OH HO
R' R'
9a-d; R' = OMe
10a-d; R' = H
14a-d; R' = H
15a-d; R' = OMe
N N
R
O O
R' R'
Co
Co(OAc)2 / EtOH, N2, 70 
o
C
or
Co(OAc)2 / THF, N2, 60 
o
C
Cu(OAc)2 / 
EtOH, H2O, 
(42-65%)
(40-87%)
 
Scheme 6. Synthesis of copper(salen) complexes 13a-d and cobalt(salen) 
complexes 14a-d and 15a-d. 
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2.2. Asymmetric cyanohydrin synthesis 
 The standard test reaction for asymmetric cyanohydrin 
synthesis used the addition of trimethylsilyl cyanide to 
benzaldehyde (Scheme 7).
21
 The cyanohydrin trimethylsilyl 
ether 16 can be converted into the corresponding acetate 17 
without racemization,
22
 and the enantiomeric excess of 
acetate 17 can be determined by chiral GC.
2
 Catalysts 11a-
d and 12a-d were screened for this reaction since our 
previous work has shown that both titanium
IV
 and 
vanadium
V
(salen) complexes are catalytically active and 
that optimal asymmetric induction is obtained with tert-
butyl groups on the aromatic rings of the salen ligand.
1,2
 
The results obtained are summarized in Table 1. 
Table 1. Use of complexes 11a-d and 12a-d as catalysts 
for the asymmetric addition of trimethylsilyl cyanide to 
benzaldehyde. 
Catalyst (mol%) Conversion (%)a ee (%) (configuration)b 
(R,R,R,R)-1 (0.1)c 100 88 (S) 
(R,R)-2a (0.1)c 87 95 (S) 
(S,S)-11a (0.1) 9 30 (R) 
(S,S)-11a (1.0) 14 22 (R) 
(S,S)-11a (2.0) 31 20 (R) 
(S,S)-11b (0.1) 20 4 (S) 
(S,S)-11b (1.0) 73 12 (S) 
(S,S)-11b (2.0) 49 11 (S) 
(R,R)-11c (0.1) 27 20 (S) 
(R,R)-11c (1.0) 56 22 (S) 
(R,R)-11c (2.0) 67 20 (S) 
(S,S)-11d (0.1) 31 46 (S) 
(S,S)-11d (1.0) 36 48 (S) 
(S,S)-11d (2.0) 61 54 (S) 
(S,S)-12a (0.1) 57 4 (S) 
(S,S)-12a (1.0) 33 1 (S) 
(S,S)-12a (2.0) 29 2 (S) 
(S,S)-12b (0.1) 24 62 (S) 
(S,S)-12b (1.0) 82 62 (S) 
(S,S)-12b (2.0) 81 64 (S) 
(R,R)-12c (0.1) 53 32 (S) 
(R,R)-12c (1.0) 62 30 (S) 
(R,R)-12c (2.0) 64 64 (S) 
(S,S)-12d (0.1) 100 81 (S) 
(S,S)-12d (1.0) 100 77 (S) 
(S,S)-12d (2.0) 100 75 (S) 
a) Conversion of benzaldehyde to mandelonitrile trimethylsilyl ether 16 
under the conditions shown in Scheme 7, determined by 1H NMR 
spectroscopy. b) Enantiomeric excess of mandelonitrile acetate 
determined by chiral GC. Absolute configuration is based on the known 
order of elution of the two enantiomers. c) data taken from reference 2. 
 
 
O
HPh
+ Me3SiCN
catalyst / CH2Cl2, 
16 hours, RT OSiMe3
CNPh
OAc
CNPh
Ac2O / Sc(OTf)3 (1 mol%),
MeCN, RT, 20 minutes
16
17
(85-100%)
 
Scheme 7. Asymmetric synthesis of mandelonitrile trimethylsilyl ether 16 
and acetate 17.  
 Each catalyst was tested at three different concentrations 
since (especially for titanium based catalysts) it is 
known
2a,19
 that enantioselectivity can increase as the 
catalyst loading is decreased due to residual water in the 
solvent being needed to convert the dichloride precatalysts 
into catalytically active di--oxo-bridged dimers. However, 
the titanium based C1-symmetrical catalysts 11a-d proved 
to be inferior to the C2-symmetrical titanium and vanadium 
complexes 1 and 2a at all concentrations. Only complex 
11d gave reasonable levels of conversion and asymmetric 
induction, but at best these were just over half the values 
obtained using catalyst 1. One mechanistically interesting 
observation was apparent from this data; whereas catalyst 
1, 11a and 11c induced preferential formation of the 
enantiomer of the cyanohydrin with opposite absolute 
configuration to that of the salen ligand, catalysts 11b and 
11d induced preferential formation of the cyanohydrin 
enantiomer with the same absolute configuration as the 
salen ligand. This suggests that catalysts 1 and 11d may 
operate by fundamentally different mechanisms. Further 
support for this hypothesis comes from the fact that for 
catalyst 11d, the conversion and enantioselectivity both 
increased as the catalyst loading increased, whereas 
previous work has shown that for the titanium dichloride 
precatalyst of complex 1, the enantioselectivity increases as 
the catalyst loading is reduced to 0.1mol%.
2a,19
 
The C1-symmetrical vanadium complexes 12a-d gave more 
encouraging results. Whilst complex 12a gave essentially 
racemic product, complexes 12b and 12c gave 
enantioselectivities up to 64%. However, the best results 
were obtained with valine derived complex 12d which gave 
complete conversion of benzaldehyde to compound 16 at 
the lowest catalyst loading and an enantioselectivity up to 
81%. This enantioselectivity was still lower than that 
obtained using catalyst 2a, but merited further 
investigation. Therefore, the use of 0.1 mol% of this 
complex to catalyze the asymmetric addition of 
trimethylsilyl cyanide to ten other aldehydes was 
investigated, giving the results presented in Table 2. 
  Where a direct comparison could be made,
2c
 the 
enantioselectivities obtained using complex 12d were 
always lower than those obtained using complex 2a. With 
the exception of electron rich 4-methoxybenzaldehyde and 
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sterically hindered pivaldehyde, the enantioselectivities 
with complex 12d were relatively independent of the 
aldehyde structure. In particular, there was no significant 
difference between the enantioselectivities observed with 
aromatic and aliphatic substrates. 
Table 2. Use of complex 12d to catalyze the asymmetric 
addition of trimethylsilyl cyanide to aldehydes. 
Aldehyde Conversion (%)a ee (%) (configuration)b 
2-MeC6H4CHO 93 66 (S) 
3-MeC6H4CHO 86 81 (S) 
4-MeC6H4CHO 90 78 (S) 
3-MeOC6H4CHO 98 66 (S) 
4-MeOC6H4CHO 100 45 (S)  
4-F3CC6H4CHO 100 77 (S) 
C8H17CHO 93 73 (S) 
Me2CHCHO 85 73 (S) 
CyCHO 91 73 (S) 
Me3CCHO 100 45 (S) 
a) Conversion of aldehyde to cyanohydrin trimethylsilyl ether under the 
conditions shown in Scheme 7, determined by 1H NMR spectroscopy. b) 
Enantiomeric excess of cyanohydrin acetate determined by chiral GC. 
Absolute configuration is based on the known order of elution of the two 
enantiomers. 
 
 The results obtained with catalysts 11a-d and 12a-d can 
be explained on the basis of the conformation of the salen 
ligand in octahedral complexes.
2e,14
 For catalysts 1 and 2, 
the cyclohexyl unit can only adopt a pseudo-equatorial 
orientation with respect to the salen ligand / metal plane 
(Figure 1) and this also locks the five-membered metal 
chelate ring into a single conformation ( for an RR-
ligand). In the case of catalysts 11 and 12 however, the 
single substituent can adopt either a pseudo-equatorial or a 
pseudo-axial position and this allows the five-membered 
metal chelate ring to adopt either a - or -conformation. 
For metal complexes with a variety of geometries, 
examples of complexes with substituents in both pseudo-
equatorial and pseudo-axial positions are known.
23
 For 
octahedral complexes (as formed by coordination of the 
aldehyde to complexes 11 and 12), interactions between the 
single substituent on the salen ligand and the axially 
coordinated groups will be dominant, especially when the 
axially coordinated groups are large.
24
 For small 
substituents (especially the methyl group in 11a and 12a), 
there is likely to be little preference for the substituent to 
adopt a pseudo-axial or pseudo-equatorial position and 
hence little preference for the chelate ring to adopt a  or -
conformation. Thus, little or no asymmetric induction 
would be expected from catalysts 11a and 12a. As the size 
of the substituent increases however, it is increasingly 
likely to adopt a pseudo-equatorial position to avoid steric 
interactions with the axially coordinated groups. This 
pseudo-equatorial preference will be especially favoured by 
the absence of a substituent on the other sp
3
-hybridized 
carbon of the salen ligand. Thus, the valine derived 
complexes 11d and 12d will have a strong preference for 
the isopropyl group to adopt the same conformation which 
is imposed upon the cyclohexyl group in complexes 1 and 2 
and this explains why complexes 11d and 12d give the 
highest levels of asymmetric induction. 
 pseudo-equatorial
pseudo-axial
N
N
M
O
O
R
H
X
X
H
X
M
N
H
R
N
O
O
X
H
R
X
M
N
H
R
N
O
O
X
H
 pseudo-equatorial  
Figure 1. Conformations of salen ligands.  
 The absolute configuration of the product produced by 
catalysts 11 and 12 will be determined by a combination of 
the orientation of the salen substituent, the conformation of 
the salen chelate ring and the coordination positions of the 
aldehyde and trimethylsilyl cyanide in the 
stereodetermining transition state. In particular, since the 
complexes lack C2-symmetry, the apical coordination 
positions (represented by X in Figure 1) are non-equivalent 
and the absolute configuration of the product is likely to be 
determined largely by which of these sites the aldehyde 
coordinates too. This can account for the changes in 
product absolute configuration relative to catalyst 
configuration observed for catalysts 11a-d and 12a-d. 
2.3. Asymmetric Strecker reactions 
 Whilst asymmetric cyanohydrin synthesis has been 
known for over a century,
21
 the closely related asymmetric 
addition of cyanide to imines has been known for only the 
last decade.
25
 Since complex 2a was known to catalyze the 
asymmetric addition of cyanide to imines,
6
 the use of 
vanadium
V
(salen) complexes 12a-d to catalyze the same 
reaction was investigated. The test reaction is shown in 
Scheme 8. Thus, addition of hydrogen cyanide (generated 
in situ from trimethylsilyl cyanide and methanol
26
) to imine 
18 generates amino nitrile 19. The enantiomeric excess of 
19 can readily be determined by 
1
H NMR analysis of its 
diastereomeric camphor sulphonate salts.
27
  
NBn
Ph
+ Me3SiCN
1) MeOH (1.2 eqiv.), toluene
2) 12a-d (10 mol%) NHBn
CNPh
18 19
(100%)
 
Scheme 8. Asymmetric addition of cyanide to imine 18.  
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 There are significant differences between the optimal 
reaction conditions required for asymmetric cyanohydrin 
synthesis and asymmetric amino nitrile synthesis. Thus, 
whilst asymmetric cyanohydrin synthesis can be achieved 
using just 0.1 mol% of catalyst at room temperature in 
dichloromethane (section 2.2), asymmetric Strecker 
reactions require the use of 10 mol% of catalyst at -40 
o
C in 
toluene in the presence of methanol. The results obtained 
using catalysts 12a-d are presented in Table 3. 
Table 3. Use of complexes 12a-d as catalysts for the 
asymmetric addition of cyanide to imine 18. 
Catalysta Conversion (%) ee (%) (configuration)b 
(R,R)-2ac 100 75 (S) 
(S,S)-12a  100 10 (S) 
(S,S)-12b 100 90 (S) 
(R,R)-12c 100 9 (R) 
(S,S)-12d 100 81 (S) 
a) All reactions were carried out using 10 mol% of catalyst under the 
conditions shown in Scheme 8. b) Enantiomeric excess and absolute 
configuration determined from the 1H NMR spectra of the camphor 
sulphonate salts. c) Result taken from reference 6 
 
 The results show a remarkable variation of 
enantioselectivity with the structure of the catalyst. 
Whereas catalysts 12a,c derived from alanine and 
phenylglycine gave negligible levels of asymmetric 
induction, catalysts 12b,d derived from phenylalanine and 
valine gave >80% asymmetric induction and were more 
effective catalysts than the C2-symmetrical catalyst 2a. All 
the reactions gave complete conversion of imine 18 into 
amino nitrile 19. The complete conversion may be due to a 
facile uncatalyzed reaction occurring during the work-up. 
The low levels of asymmetric induction observed with 
complexes 12a,c could be due to a very slow but highly 
enantioselective reaction, rather than a non-stereoselective 
reaction. The same effect may also be responsible for the 
apparent difference in enantioselectivity between 
complexes 12b and 12d. For all four of catalysts 12a-d, 
amino nitrile 19 had the same absolute configuration as the 
catalyst. In contrast, the (R,R)-enantiomer of catalyst 2a 
formed the (S)-enantiomer of amino nitrile 19. This is 
consistent with the mono-substituted ligands adopting a 
structure with a different substituent location and / or 
chelate ring conformation to the cyclohexanediamine 
derived ligand. Further work is underway to investigate the 
mechanistic and stereochemical aspects of this reaction and 
to extend it to other substrates, and will be reported in due 
course. 
2.4. Asymmetric alkylation of amino ester enolates 
 Asymmetric phase transfer catalysis is usually carried 
out using organocatalysts such as cinchona alkaloid 
derivatives
28
 or spiro-ammonium salts.
29
 However, we have 
previously developed C2-symmetrical salen complexes 3a,b 
as the first transition metal based catalysts for the 
asymmetric alkylation of enolates under solid-liquid phase 
transfer conditions.
1,8,9
 Therefore it was of interest to 
investigate the use of C1-symmetrical complexes 13a-d and 
14a-d as catalysts for the same reaction. 
 The standard test reaction used to compare catalysts for 
asymmetric enolate alkylation is shown in Scheme 9. This 
has the advantage that alanine derivative 20 is readily 
available and product 21 is not susceptible to racemization. 
In addition, the enantiomeric excess of product 21 is readily 
determined by 
1
H NMR analysis after derivatization with 
(S)-1-phenylethylisocyanate to give diastereomeric ureas 
22. We have previously shown that no kinetic resolution 
occurs during this derivatization.
9
 The results obtained 
using catalysts 13a-d and 14a-d are given in Table 4. 
Me
CO2MeN
Cl
Me
CO2MeH2N
Ph
20
21
CO2MeN
H
Me Ph
N
H
O
Ph
Me
22
Ph N=C=O
Me
1) NaOH (solid) / PhCH2Br,
    13a-d or 14a-d (2 mol%) /
    toluene, argon, 16 hours
2) MeOH / AcCl, argon, 4 hours
3) SiO2
(66-91%)
 
Scheme 9. Use of complexes 13a-d and 14a-d as catalysts for enolate 
alkylation under solid-liquid phase transfer conditions.  
 It is apparent that all of catalysts 13a-d and 14a-d were 
significantly inferior to the C2-symmetrical catalysts 3a,b. 
In contrast to asymmetric cyanohydrin and amino nitrile 
synthesis, the highest levels of asymmetric induction were 
obtained with complexes derived from alanine and 
phenylalanine rather than valine. Interestingly, in this case 
the relationship between the absolute configuration of the 
catalyst and the product did not vary between the C2- and 
C1-symmetrical catalysts. Thus, for catalysts 3a,b, 13a,b 
and 14a,b the product had the same absolute configuration 
as the catalyst. Only in the case of phenylglycine derived 
catalysts 13c and 14c was this trend not followed and the 
enantiomeric excesses were very low (<10%) in this case. 
In view of the low enantioselectivities obtained in this 
reaction, the use of catalysts 13a-d and 14a-d for the 
asymmetric synthesis of -methyl -amino acids was not 
pursued further. 
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Table 4. Use of complexes 13a-d and 14a-d as catalysts 
for the asymmetric alkylation of alanine derivative 20.
a 
Catalyst Yield of 21 (%) ee (%) (configuration)b 
(R,R)-3ac 91 81 (R) 
(R,R)-3bc 83 80 (R) 
(S,S)-13a 72 27 (S) 
(S,S)-13b  79 27 (S) 
(R,R)-13c 69 6 (S) 
(S,S)-13d 67 0 
(S,S)-14a 70 24 (S) 
(S,S)-14b 84 29 (S) 
(R,R)-14c 73 9 (S) 
(S,S)-14d 66 0 
a) All reactions carried out using 2 mol% of catalyst under the 
conditions shown in Scheme 9. b) Enantiomeric excess and absolute 
configuration determined from the 1H NMR spectra of ureas 22. c) Data 
taken from reference 9b 
 
2.5. Asymmetric Darzens condensations 
 The Darzens condensation of -haloamides 23 and 24 
with benzaldehyde is catalyzed by C2-symmetrical complex 
4.
10
 The diastereoselectivity of the reaction is dependent on 
the halide present in substrate 23 / 24, with chloroamide 23 
giving predominantly trans-epoxide 26 whilst bromoamide 
24 gives predominantly cis-epoxide 25. Therefore, the 
ability of the corresponding C1-symmetrical cobalt
II
(salen) 
complexes 15a-d to influence both the enantio- and 
diastereoselectivity of this reaction was studied. The 
standard conditions used to study this reaction are shown in 
Scheme 10. The enantiomeric excess of epoxides 25 and 26 
could be determined by chiral HPLC. The results obtained 
using catalysts 15a-d are presented in Table 5. 
(72-97%)
PhCHO + XCH2CONPh2
KOH (solid) /
15a-d (2 mol%),
CH2Cl2, RT, 4 hours
23: X = Cl
24: X = Br
O
Ph CONPh2
25
O
Ph CONPh2
26
+
 
Scheme 10. Use of complexes 15a-d to catalyze asymmetric Darzens 
condensations.  
 None of the C1-symmetrical catalysts came close to 
matching the enantioselectivities achieved with C2-
symmetrical catalyst 4 with either substrate 23 or 24. Only 
complex 15a derived from alanine showed any significant 
asymmetric induction. For the major diastereomer of the 
epoxide product, the observed enantiomeric excess was still 
less than half that obtained using catalyst 4. 
 
Table 5. Use of complexes 15a-d as catalysts for the 
asymmetric Darzens condensation of substrates 23 and 24.
a 
Catalyst Substrate 25 / 26b ee 25c ee 26c Yield %d 
Nonee 23 1 : 1.8   73 
Nonee 24 2.4 : 1   78 
(R,R)-4f 23 1 : 2.7 3 29 84 
(R,R)-4f 24 2.4 : 1 42 44 93 
(S,S)-15a 23 1 : 2.3 4 11 97 
(S,S)-15a  24 2.6 : 1 18 21 83 
(S,S)-15b 23 1 : 2.9 5 5 86 
(S,S)-15b 24 2.4 : 1 2 0 79 
(R,R)-15c 23 1 : 3.8 3 8 72 
(R,R)-15c 24 2.2 : 1 12 11 79 
(S,S)-15d 23 1 : 3.8 2 8 80 
(S,S)-15d 24 2.3 : 1 0 2 79 
a) All reactions carried out using 2 mol% of catalyst under the 
conditions shown in Scheme 10. b) Determined by 1H NMR 
spectroscopy. c) Determined by chiral HPLC. d) Combined yield of 
epoxides 25 and 26. e) Data taken from reference 10a. f) Data taken 
from reference 10b 
 
 The results also show that when bromoamide 24 was 
used, the diastereoselectivity was independent of the 
catalyst used and indeed stayed the same if no catalyst was 
employed. In every case, the cis-epoxide 25 was the major 
product and the cis/ trans ratio was approximately 2.4 : 1. 
In contrast, for reactions carried out on chloroamide 23, the 
observed diastereoselectivity was catalyst dependent. In 
every case, trans-epoxide 26 was the major product, but the 
cis/ trans ratio changed from 1 : 1.8 (64% trans) when no 
catalyst was used to 1 : 3.8 (79% trans) in the presence of 
catalysts 15c,d. Exactly how the catalysts are able to 
influence the diastereoselectivity of reactions involving 
substrate 23 without inducing asymmetry into the reaction 
is not clear. The Darzens reaction is mechanistically 
complex involving enolate formation, an aldol reaction and 
intramolecular substitution and under the reaction 
conditions all of these steps may be reversible.
30
 We have 
previously analyzed Darzens reactions on substrates 23 and 
24 in terms of 24 giving epoxide 25 via a kinetically 
controlled, non-chelated aldol reaction, whilst chloroamide 
23 reacts via a thermodynamically controlled chelated aldol 
reaction due to the lower leaving group ability of chloride 
compared to bromide.
10
 Thus, it may be that complexes 
15a-d also coordinate to the chelated aldol intermediate and 
do so in such a way as to enhance the preference for all 
substituents to adopt equatorial positions in the six-
membered chelate, whilst being too remote to influence the 
absolute configuration of the newly formed stereocenters. 
One possible structure for such an intermediate is shown in 
Figure 2, but the heterogeneous nature of these reactions 
has prevented experimental confirmation of this type of 
intermediate. 
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Figure 2. Possible chelated intermediate to explain the diastereoselectivity 
of reactions involving substrate 23 and catalysts 15a-d.  
3. Conclusions 
 C1-symmetrical salen ligands derived from four different 
amino acids have been prepared and complexed to four 
different metal ions to give catalysts for four different 
carbon-carbon bond forming reactions. Application of 
titanium
IV
 and vanadium
V
 complexes to asymmetric 
cyanohydrin synthesis gave satisfactory levels of 
asymmetric induction in some cases (especially with 
complex 12d), though in no case were the 
enantioselectivities as high as those obtained using the 
corresponding C2-symmetrical catalysts 1 and 2. In 
contrast, use of the same vanadium
V
 complexes to catalyze 
asymmetric Strecker reactions did, in two cases, give 
higher levels of asymmetric induction than those obtained 
using C2-symmetrical complex 2a. 
 The use of C1-symmetrical salen complexes as 
asymmetric catalysts for enolate reactions conducted under 
phase transfer conditions was also investigated. Complexes 
13a,b and 14a,b did show enantioselectivities of 20-30% in 
the asymmetric synthesis of -methyl-phenylalanine 
methyl ester, but these were far lower than the 80-81% 
enantiomeric excess achievable using C2-symmetrical 
catalysts 3a,b. The use of complexes 15a-d as asymmetric 
catalysts for the Darzens condensation was also studied 
under phase transfer conditions. Again, no significant 
levels of asymmetric induction were achieved, though the  
catalysts were able to enhance the diastereoselectivity of 
reactions involving chloroamide substrate 23. 
4. Experimental 
4.1. General methods 
 1
H and 
13
C NMR spectra were recorded in CDCl3 using 
Bruker Avance spectrometers. 
1
H NMR spectra were 
recorded at 300 or 360 MHz. 
13
C NMR spectra were 
recorded at 75 or 90MHz. All chemical shifts (δ) are quoted 
in parts per million (ppm) relative to tetramethylsilane 
using the residual solvent peak as an internal standard and 
all coupling constants (J) are quoted in Hertz. Multiplicities 
are reported as singlet (s), doublet (d), triplet (t), quartet 
(q), multiplet (m) or a combination of these. Low and high 
resolution mass spectra were recorded by the EPSRC 
national service, or by King’s College London using 
electron ionization (EI), chemical ionization (CI) or 
electrospray ionization (ESI). IR spectra of solids were 
recorded on a Thermo electron corporation Nicolet Avatar 
370 DTGS: Smart Orbit Diamond ATR 30000-200cm
-1
. IR 
spectra of liquids and oils were recorded as a thin film 
between NaCl plates on a Perkin-Elmer Spectrum One FT-
IR spectrometer. The strength of the vibrations are quoted 
as broad (br), strong (s), medium (m) or weak (w). Optical 
rotation measurements were undertaken using an Optical 
Activity POLAAR 2001 polarimeter and melting points 
were recorded using Barnstead Electrothermal 9100 
melting point apparatus. 
 Gas chromatography was carried out using a Hewlett 
Packard 5890 Series II Plus instrument fitted with a TCD 
detector using a Supelco Gamma DEX 120 fused silica 
capillary column (30 m  0.25 mm) with hydrogen as the 
carrier gas. High performance liquid chromatography was 
conducted on a Varian Pro Star 410 system using a Daicel 
Chiralpak ADH column with UV detection at 254 nm and a 
solvent system of hexane / isopropanol (4 : 1) with a flow 
rate of 1 mL / minute. All silica gel chromatography was 
performed using either Merck silica gel 60 (0.04-0.063mm) 
or Fluorochem silica gel 40-63μ 60A. 
4.2. General procedure for the synthesis of ligands 
8a,c,d, 9a,c,d and 10a,c,d. 
 Amino amide
15
 6a-d (1.0 equiv.) and lithium aluminium 
hydride (3.0 equiv.) were dissolved in dry THF at 0 °C 
under a nitrogen atmosphere. The reaction mixture was 
then refluxed under nitrogen for 16-72 hours, and was then 
allowed to cool to room temperature. The reaction mixture 
was then cooled to 0 °C and 1% aqueous potassium 
hydroxide solution was slowly added. The resulting 
precipitate was filtered and washed with toluene. The 
toluene washings were dried (Na2CO3), filtered and 
methanol and acetyl chloride (3.0 equiv.) were added. The 
mixture was then left to stir at room temperature overnight, 
at which time the diamine dihydrochloride salt precipitated 
as a white solid. The precipitate was filtered and air dried. 
Diethyl ether was added to the filtrate and left to stir for 
another 20 minutes resulting in the precipitation of a 
second batch of dihydrochloride salt which was filtered and 
air dried. The combined crops of the diamine 
dihydrochloride salt were then dissolved in methanol and 
ethanol (1:1) and sodium methoxide (3.0 equiv.) and the 
appropriate salicylaldehyde derivative (2.0 equiv.) were 
added. The solution was then refluxed overnight, cooled to 
room temperature, filtered and concentrated in vacuo. The 
residue was taken up in CH2Cl2, filtered, washed 
successively with distilled water (2 x 30 mL) and brine (1 x 
30 mL), dried (Na2SO4), filtered and concentrated in vacuo 
to give ligands 8a,c,d, 9a,c,d and 10a,c,d. 
4.2.1. (2S)-[N,N’-bis-(2’-hydroxy-3’,5’-di-tert-butyl 
benzylidene)]-1,2-diaminopropane 8a.
17a,b
 
 Obtained as a yellow gel (80%). [α]D
20
 +173.0 (c 0.1, 
CHCl3). υmax 3584 (br), 2960 (s), 2908 (s), 2869 (s), 1630 
(s) and 1597 cm
-1
 (m). δH 1.19 (18H, s), 1.29 (3H, d J 5.9 
Hz), 1.34 (9H, s), 1.35 (9H, s), 3.5-3.7 (2H, m), 3.7-3.8 
(1H, m), 6.9-7.0 (2H, m), 7.2-7.3 (2H, m), 8.25 (1H, s), 
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8.29 (1H, s), 13.70 (2H, br s). δc 20.4, 29.4, 29.6, 29.7, 
31.3, 31.4, 31.5, 34.1, 35.1, 63.9, 64.9, 118.0, 118.1, 126.0, 
126.1, 126.9, 127.0, 136.8, 136.9, 140.1, 140.2, 158.1, 
158.2, 165.6, 167.5. m/z (ESI) 529.3 (M+Na
+
, 100), 507.3 
(MH
+
, 18), 64.0 (46). Found (ESI) 507.3948 (MH
+
, 
C33H51N2O2 requires 507.3945). 
4.2.2. (1R)-[N,N’-bis-(2’-hydroxy-3’,5’-di-tert-butyl 
benzylidene)]- 1-phenyl-1,2-diaminoethane 8c.
17c
 
 Obtained as a yellow gel (72%) after purification by 
column chromatography on silica gel using 
dichloromethane as eluent. [α]D
20
 -27.2 (c 0.25, CHCl3). 
υmax 3434 (br), 2958 (s), 2869 (m) and 1629 cm
-1
 (s). δH 
1.33-1.35 (18H, m), 1.50-1.54 (18H, m), 3.9-4.1 (1H, m), 
4.2-4.3 (1H, m), 4.7-4.8 (1H, m), 7.1-7.2 (2H, m), 7.4-7.5 
(5H, m), 7.5-7.6 (2H, m), 8.52 (1H, s), 8.62 (1H, s), 13.66 
(2H, br s). δc 29.5, 29.6, 31.4, 31.5, 34.4, 35.4, 66.8, 74.4, 
117.1, 118.1, 126.1, 126.4, 127.1, 127.2, 127.3, 127.7, 
128.8, 136.7, 136.8, 140.1, 140.3, 141.0, 158.1, 158.2, 
167.1, 167.9. m/z (ESI) 583.4 (MH
+
, 100), 367.2 (25), 
234.0 (18), 79.0 (41). Found (ESI) 583.4258 (MH
+
, 
C39H55N2O2 requires 583.4258). 
4.2.3. (2S)-[N,N’-bis-(2’-hydroxy-3’,5’-di-tert-butyl 
benzylidene)]-3-methyl-1,2-diaminobutane 8d. 
 Obtained as a yellow gel (62%) after purification by 
column chromatography on silica gel using hexane as 
eluent. [α]D
20
 +84.0 (c 0.1, CHCl3). υmax 3435 (br), 2960 (s), 
2871 (m) and 1630 cm
-1
 (s). δH 0.92 (3H, d J 3.9 Hz), 0.94 
(3H, d JH 3.9 Hz), 1.17 (9H, s), 1.19 (9H, s), 1.32 (9H, s), 
1.35 (9H, s), 1.9-2.0 (1H, m), 3.1-3.2 (1H, m), 3.56 (1H, dd 
J 12.2, 8.4 Hz), 3.86 (1H, dd J 12.2, 2.9 Hz), 6.9-7.0 (2H, 
m), 7.2-7.3 (2H, m), 8.22 (1H, s), 8.23 (1H, s), 13.60 (2H, 
br s). δc 18.4, 19.9, 29.5, 29.6, 29.7, 29.8, 31.4, 31.5, 34.1, 
35.1, 62.5, 76.1, 118.0, 118.1, 126.0, 126.2, 127.0, 136.7, 
136.8, 140.1, 140.2, 158.2, 158.3, 166.6, 167.5. m/z (CI) 
535.4 (MH
+
, 53), 88.1 (23), 86.0 (68), 74.0 (100). Found 
(ESI) 535.4252 (MH
+
 C35H55N2O2 requires 535.4258).  
4.2.4. (2S)-[N,N’-bis-(2’-hydroxy-4’-methoxy 
benzylidene)]-1,2-diaminopropane 9a. 
 Obtained as a yellow gel (65%). [α]D
20
 +425.0 (c 0.04, 
CHCl3). υmax 2967 (m), 1623 (s) and 1515 cm
-1
 (m). δH 1.28 
(3H, d J 6.2 Hz), 3.4-3.6 (2H, m), 3.70 (3H, s), 3.71 (3H, 
s), 3.73 (1H, broad s), 6.2-6.4 (4H, m), 6.9-7.0 (2H, m), 
8.06 (1H, s), 8.12 (1H, s), 13.70 (2H, br s). δc 20.5, 55.3, 
55.6, 64.5, 65.4, 101.4, 106.3, 106.4, 106.5, 108.3, 112.9, 
121.0, 129.3, 133.0, 135.1, 163.5, 163.6, 164.7, 165.7. m/z 
(ESI) 343.3 (MH
+
, 100%). Found (ESI) 343.1651 (MH
+
, 
C19H23N2O4 requires 343.1652).  
4.2.5. (1R)-[N,N’-bis-(2’-hydroxy-4’-methoxy 
benzylidene)]-1-phenyl-1,2-diaminoethane 9c. 
 Obtained as a yellow gel (53%) after purification by 
column chromatography on silica gel using diethyl ether as 
eluent. [α]D
20
 -60.0 (c 0.06, CHCl3). υmax 3428, 1623 and 
1514 cm
-1
 (m). δH 3.68 (3H, s), 3.69 (3H, s), 3.7-3.8 (1H, 
m), 3.9-4.0 (1H, m), 4.48 (1H, dd J 8.2, 4.5 Hz), 6.2-6.4 
(4H, m), 6.9-7.0 (2H, m), 7.1-7.4 (5H, m), 8.01 (1H, s), 
8.18 (1H, s), 13.74 (2H, br s). δc 55.2, 55.3, 65.9, 73.5, 
101.3, 101.4, 106.4, 106.5, 112.6, 112.7, 127.0, 127.3, 
127.6, 128.6, 128.7, 132.7, 133.0, 140.8, 163.7, 163.8, 
164.8, 165.7. m/z (ESI) 405.2 (MH
+
, 100), 242.0 (10). 
Found (ESI) 405.1807 (MH
+
 C24H25N2O4 requires 
405.1809).  
4.2.6. (2S)-[N,N’-bis-(2’-hydroxy-4’-methoxy 
benzylidene)]-3-methyl-1,2-diaminobutane 9d. 
 Obtained as a yellow gel (61%) after purification by 
column chromatography on silica gel using hexane as 
eluent. [α]D
20
 +78.6 (c 0.5, CHCl3). υmax 3467 (br), 2962 
(m), 1626 (s), 1579 (m) and 1515 cm
-1
 (m). δH 0.99 (3H, d 
J 3.2 Hz), 1.01 (3H, d J 3.2 Hz), 1.9-2.1 (1H, m), 3.1-3.3 
(1H, m), 3.55 (1H, dd J 12.3, 8.5 Hz), 3.77 (3H, s), 3.78 
(3H, s), 3.87 (1H, dd J 12.4, 2.8 Hz), 6.3-6.4 (4H, m), 7.0-
7.1 (2H, m), 8.10 (1H, s), 8.12 (1H, s), 13.86 (2H, br s). δc 
18.0, 19.7, 31.2, 55.1, 55.2, 61.6, 75.1, 101.3, 106.2, 106.3, 
112.4, 112.5, 132.5, 132.6, 132.7, 132.8, 163.5, 164.3, 
164.5, 165.3. m/z (ESI) 371.3 (MH
+
, 47), 151.9 (63), 139.0 
(85), 125.1 (60), 103.0 (36), 86.0 (100), 72.0 (42). Found 
(ESI) 371.1966 (MH
+
 C21H27N2O4 requires 371.1965).  
4.2.7. (2S)-[N,N’-bis-(2’-hydroxybenzylidene)]-1,2-
diaminopropane 10a. 
 Obtained as a yellow solid (100%). Mp 51.7-51.9 °C. 
[α]D
20
 +332.0 (c 0.05, CHCl3). υmax 3400 (br), 2971 (m), 
2883 (m), 1631 (s) and 1581 cm
-1
 (m). δH 1.29 (3H, d J 6.1 
Hz), 3.5-3.7 (2H, m), 3.7-3.8 (1H, m), 6.7-6.9 (4H, m), 7.1-
7.2 (4H, m), 8.21 (1H, s), 8.25 (1H, s), 12.62 (2H, br s). δc 
20.6, 65.3, 66.3, 116.9, 117.0, 118.5, 118.6, 118.8, 129.0, 
131.4, 131.5, 132.3, 132.4, 161.1, 161.2, 164.4, 166.4. m/z 
(ESI) 283.2 (MH
+
, 100), 179.1 (19), 122.0 (5). Found 
283.1439 (MH
+
 C17H19N2O2 requires 283.1441).  
4.2.8. (1R)-[N,N’-bis-(2’-hydroxybenzylidene)]-1-
phenyl-1,2-diaminoethane 10c. 
 This ligand was unstable to chromatography on silica 
gel and could not be purified. Therefore, the impure ligand 
was used for complex preparation without characterization. 
4.2.9. (2S)-[N,N’-bis-(2’-hydroxybenzylidene)]-3-methyl-
1,2-diaminobutane 10d. 
 Obtained as a yellow gel (50%) after purification by 
column chromatography on silica gel using Et2O as eluent. 
[α]D
20
 +250.0 (c 0.03, CHCl3). υmax 3376 (br), 3051 (m), 
2959 (m), 2872 (m), 1631 (s) and 1580 cm
-1
 (m). δH 0.8-0.9 
(6H, m), 1.8-2.0 (1H, m), 3.1-3.2 (1H, m), 3.24 (1H, dd J 
6.5, 1.2 Hz), 3.80 (1H, ddd J 12.3, 3.7, 1.2 Hz), 6.6-6.8 
(2H, m), 6.8-6.9 (2H, m), 7.0-7.1 (2H, m), 7.1-7.2 (2H, m), 
8.10 (1H, s), 8.12 (1H, s). δc 19.7, 20.1, 31.5, 62.9, 76.2, 
117.7, 119.8, 120.9, 128.3, 128.4, 130.1, 130.2, 133.6, 
136.8, 155.8, 161.6, 165.1, 165.7, 166.8. m/z (ESI) 311.2 
(MH
+
, 100), 207.1 (43), 178.1 (26), 122.0 (10), 74.2 (20). 
Found (ESI) 311.1752 (MH
+
 C19H23N2O2 requires 
311.1754).  
4.3. General procedure for the synthesis of ligands 8-
10b. 
 Amino amide
15b
 6b (1.0 equiv.) and lithium aluminium 
hydride (3.0 equiv.) were dissolved in dry THF at 0 °C 
under a nitrogen atmosphere. The reaction mixture was 
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then refluxed under nitrogen for 16-72 hours, and was then 
allowed to cool to room temperature. The reaction mixture 
was then cooled to 0°C and 1% aqueous potassium 
hydroxide solution was slowly added. The resulting 
precipitate was filtered and washed with toluene. The 
toluene washings were dried (Na2CO3), filtered and 
evaporated to give diamine 7b which was immediately 
dissolved in ethanol and the appropriate substituted 
salicylaldehyde (2.0 equiv.) was added. The solution was 
refluxed for 20 hours, cooled to room temperature, filtered 
and concentrated in vacuo. The residue was then taken up 
in CH2Cl2, filtered, washed successively with distilled 
water (2 x 30 mL) and brine (1 x 30 mL), dried (Na2SO4), 
filtered and concentrated in vacuo to give ligands 8-10b. 
4.3.1. (2S)-[N,N’- bis-(2’-hydroxy-3’,5’-di-tert-butyl 
benzylidene)]-3-phenyl-1,2-diaminopropane 8b.
17c
 
 Obtained as yellow crystals (58%) after purification by 
column chromatography on silica gel using 
dichloromethane as eluent. Mp 165.2-166.5 °C (decomp.). 
[α]D
20
 +63.5 (c 0.052, CHCl3). υmax 3411 (br), 2958 (s), 
2868 (m) and 1629 cm
-1
 (s). δH 1.15 (9H, s), 1.17 (9H, s), 
1.32 (9H, s), 1.33 (9H, s), 2.9-3.0 (2H, m), 3.5-3.7 (2H, m), 
3.82 (1H, dd J 11.1, 2.1 Hz), 6.84 (1H, d J 2.4 Hz), 6.94 
(1H, d J 2.4 Hz), 7.01-7.2 (1H, m), 7.25 (1H, t J 2.2 Hz), 
8.04 (1H, s), 8.23 (1H, s), 13.69 (2H, br s). δc 29.5, 29.6, 
31.4, 31.5, 34.1, 34.2, 35.1, 41.1, 64.0, 71.4, 117.9, 118.0, 
126.0, 126.2, 126.5, 127.0, 127.1, 128.5, 129.6, 136.7, 
136.8, 138.2, 140.1, 140.2, 158.1, 158.2, 166.6, 167.8. m/z 
(CI) 569.5 (MH
+
, 38), 234.2 (100), 106.0 (52), 52.2 (73). 
Found (ESI) 569.4104 (MH
+
 C38H53N2O2 requires 
569.4102). 
4.3.2. (2S)-[N,N’- bis-(2’-hydroxy-4’-methoxy 
benzylidene)]-3-phenyl-1,2-diaminopropane 9b. 
 Obtained as a yellow gel (48%) after purification by 
column chromatography on silica gel using diethyl ether as 
eluent. [α]D
20
 +67.0 (c 0.06, CHCl3). υmax 3434 (br), 1623 
(s) and 1514 cm
-1
 (m). δH 2.83 (1H, dd J 13.4, 7.5 Hz), 2.97 
(1H, dd J 13.6, 4.5 Hz), 3.5-3.6 (2H, m), 3.70 (6H, s), 3.7-
3.8 (1H, m), 6.2-6.4 (4H, m), 6.8-6.9 (1H, m), 6.9-7.0 (1H, 
m), 7.0-7.3 (5H, m), 7.81 (1H, s), 8.06 (1H, s), 13.63 (2H, 
br s). δc 41.3, 55.6, 63.7, 63.8, 71.3, 101.7, 106.8, 112.9, 
125.8, 128.8, 129.9, 133.1, 138.3, 164.0, 164.4, 164.8, 
166.0. m/z (ESI) 419.3 (MH
+
, 6), 307.2 (17), 285.2 (100), 
152.0 (98). Found (ESI) 419.1962 (MH
+
 C25H27N2O4 
requires 419.1965).  
4.3.3. (2S)-[N,N’- bis-(2’-hydroxybenzylidene)]-3-
phenyl-1,2-diaminopropane 10b. 
 Obtained as yellow crystals (51%) after recrystallization 
from hexane. Mp 97.1-97.3 °C. [α]D
20
 +88.0 (c 0.05, 
CHCl3). υmax 3250 (br), 3055 (w), 3023 (w), 2912 (w), 
1627 (s), 1609 (m) and 1578 cm
-1
 (m). δH 2.9-3.0 (1H, m), 
3.1-3.2 (1H, m), 3.7-3.8 (2H, m), 4.0-4.1 (1H, m), 6.7-6.9 
(2H, m), 6.9-7.0 (2H, m), 7.08 (1H, dd J 7.6, 1.6 Hz), 7.1-
7.3 (8H, m), 8.00 (1H, s), 8.29 (1H, s), 13.17 (2H, s). δc 
41.3, 64.5, 71.9, 117.4, 119.0, 127.0, 128.9, 129.9, 131.8, 
131.9, 132.7, 138.1, 161.5, 165.8, 167.1. m/z (ESI) 359.3 
(MH
+
, 68), 255.2 (33), 122.0 (100), 105.0 (20). Found 
359.1753 (MH
+
 C23H23N2O2 requires 359.1754).  
4.4. General procedure for the synthesis of titanium 
dichloride complexes 11a-d. 
 A mixture of ligand 8a-d (1 equiv.) and TiCl4 (1 M 
solution in CH2Cl2; 1 equiv.) was stirred at room 
temperature under an argon atmosphere in dry CH2Cl2 for 
three hours. The reaction was concentrated in vacuo and the 
residue washed with Et2O and with 1:1 Et2O / petroleum 
ether to give complexes 11a-d. 
4.4.1. [(2S)-[N,N’-bis-(2’-hydroxy-3’,5’-di-tert-butyl 
benzylidene)]-1,2-diaminopropanato] titanium
IV
 
chloride 11a. 
 Obtained as a red / brown solid (100%). Mp 351.1-352.0 
°C (decomp.). [α]D
20
 +800.0 (c 0.003, CHCl3). υmax 2953 
(m), 2906 (m), 2868 (m), 1615 (s) and 1562 cm
-1
 (m). δH 
1.22 (9H, s), 1.24 (9H, s), 1.42 (18H, s), 1.46 (3H, d J 6.4 
Hz), 3.9-4.0 (2H, m), 4.4-4.5 (1H, m), 7.2-7.3 (2H, m), 7.5-
7.6 (2H, m), 8.20 (1H, s), 8.21 (1H, s). δc 16.7, 17.3, 30.0, 
30.9, 31.3, 31.4, 34.5, 34.6, 35.6, 61.5, 65.6, 125.4, 125.9, 
129.4, 129.9, 131.3, 131.5, 135.2, 137.2, 144.6, 144.7, 
159.7, 160.4, 162.4, 164.3. m/z (EI) 622.3 (M
+
, 13), 587.3 
(M-Cl
+
, 100). Found (EI) 622.2565 (M
+
 
C33H48N2O2
48
Ti
35
Cl2 requires 622.2567).  
4.4.2. [(2S)-[N,N’- bis-(2’-hydroxy-3’,5’-di-tert-butyl 
benzylidene)]-3-phenyl-1,2-diaminopropanato] 
titanium
IV
 chloride 11b. 
 Obtained as a red / brown solid (100%). Mp 291.0-291.4 
°C (decomp.). [α]D
20
 -266.7 (c 0.006, CHCl3). υmax 2953 (s), 
2866 (m), 1608 (s), 1559 (s) and 1546 cm
-1
 (s). δH 1.20 
(9H, s), 1.22 (9H, s), 1.43 (9H, s), 1.45 (9H, s), 2.97 (1H, 
dd, J 13.2, 6.5 Hz), 3.47 (1H, dd, J 13.1, 8.6 Hz), 3.7-3.8 
(1H, m), 4.1-4.2 (1H, m), 4.40 (1H, dd J 13.1, 5.4 Hz), 6.85 
(1H, d J 2.2 Hz), 7.2-7.3 (1H, m), 7.4-7.5 (2H, m), 7.59 
(1H, s), 8.23 (1H, s). δc 29.4, 30.0, 31.2, 31.3, 34.4, 34.5, 
35.5, 35.6, 41.2, 63.7, 69.8, 125.3, 127.1, 127.7, 128.0, 
129.0, 129.5, 129.8, 131.4, 131.7, 137.1, 137.2, 137.4, 
144.5, 144.6, 159.9, 160.9, 164.5, 165.2. m/z (EI) 663.4 
(M-Cl
+
, 26), 234.3 (20), 219.2 (100), 86.1 (31), 84.1 (48), 
48.9 (26). Found (EI) 698.2879 (M
+ 
C39H52N2O2
48
Ti
35
Cl2 
requires 698.2880). 
4.4.3. [(1R)-[N,N’-bis-(2’-hydroxy-3’,5’-di-tert-butyl 
benzylidene)]- 1-phenyl-1,2-diaminoethanato] 
titanium
IV
 chloride 11c. 
 Obtained as a red / brown solid (100%). Mp 368.2-369.0 
°C (decomp.). [α]D
20
 +1300.0 (c 0.004, CHCl3). υmax 2956 
(s), 2868 (m), 1614 (s), 1560 (m) and 1547 cm
-1
 (m). δH 
1.18 (9H, s), 1.26 (9H, s), 1.45 (9H, s), 1.47 (9H, s), 3.86 
(1H, dd, J 13.6, 5.3 Hz), 4.7-4.8 (1H, m), 5.3-5.4 (1H, m), 
6.92 (1H, d J 2.3 Hz), 7.26 (1H, d J 2.3 Hz), 7.3-7.4 (2H, 
m), 7.4-7.5 (3H, m), 7.48 (1H, d J 2.3 Hz), 7.5-7.6 (1H, m), 
7.71 (1H, d J 2.1 Hz), 8.25 (1H, d J 1.5 Hz). δc 30.1, 31.3, 
31.4, 34.5, 34.6, 35.6, 35.7, 65.8, 70.0, 125.5, 125.6, 125.9, 
126.0, 129.5, 129.7, 129.8, 130.0, 131.4, 131.5, 135.4, 
137.2, 137.3, 144.7, 144.8, 159.6, 164.0, 164.2. m/z (EI) 
684.2 (M
+
, 100), 630.3 (20), 126.9 (20). Found (EI) 
684.2723 (M
+
 C38H50N2O2
48
Ti
35
Cl2 requires 684.2723).  
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4.4.4. [(2S)-[N,N’-bis-(2’-hydroxy-3’,5’-di-tert-butyl 
benzylidene)]-3-methyl-1,2-diaminobutanato] 
titanium
IV
 chloride 11d. 
 Obtained as a red / brown solid (100%). Mp 163.6-163.8 
°C (decomp.). [α]D
20
 -240.0 (c 0.005, CHCl3). υmax 2955 (s), 
2869 (m), 1606 (s) and 1543 cm
-1
 (s). δH 0.92 (3H, d J 6.7 
Hz), 0.94 (3H, d J 6.7 Hz), 1.23 (9H, s), 1.25 (9H, s), 1.42 
(9H, s), 1.44 (9H, s), 2.3-2.5 (1H, m), 3.6-3.7 (1H, m), 3.95 
(1H, dd, J 13.5, 3.4 Hz), 4.32 (1H, dd J 12.7, 5.0 Hz), 7.2-
7.3 (2H, m), 7.5-7.6 (2H, m), 8.23 (1H, s), 8.29 (1H, s). δc 
18.8, 19.5, 20.2, 26.7, 29.6, 29.7, 31.1, 31.3, 34.4, 34.6, 
35.5, 60.9, 74.6, 125.2, 125.3, 129.4, 129.8, 131.4, 131.5, 
137.0, 137.1, 144.3, 144.4, 160.0, 160.7, 164.7, 165.0. m/z 
(EI) 615.3 (M-Cl
+
, 10), 234.2 (21), 219.2 (100), 57 (9). 
Found (EI) 648.2928 (M
+
 C35H52N2O2
46
Ti
35
Cl2 requires 
648.2927). 
4.5. General procedure for the synthesis of vanadium 
oxychloride complexes 12a-c. 
 Ligand 8a-c (1.0 equiv.) and vanadyl sulphate hydrate 
(1.8 equiv.) were dissolved in dry ethanol with gentle 
warming.  Dry THF was added and the solution was 
refluxed for three hours. The solution was then allowed to 
cool to room temperature and the solvent was removed in 
vacuo. The residue was taken up in acetonitrile and ceric 
ammonium nitrate (1.2 equiv.) was added. The mixture was 
stirred at room temperature for ten minutes, then the 
solvent was removed in vacuo. The residue was taken up in 
dichloromethane, washed with 1M aqueous hydrochloric 
acid and brine, dried (Na2SO4), filtered and concentrated in 
vacuo. The residue was purified by column 
chromatography on silica gel using first CH2Cl2, then 
EtOAc / MeOH (2:1) as eluents to give complexes 12a-c. 
4.5.1. [(2S)-[N,N’-bis-(2’-hydroxy-3’,5’-di-tert-butyl 
benzylidene)]-1,2-diaminopropanato] vanadium
V
 
chloride 12a. 
 Obtained as a green solid (50%). Mp 164.1-164.4 °C. 
[α]D
20
 +1050.0 (c 0.002, CHCl3). υmax 2955 (m), 2868 (m), 
1615 (s) and 1549 cm
-1
 (m). δH 1.28 (9H, s), 1.30 (9H, s), 
1.4-1.5 (21H, m), 3.9-4.0 (2H, m), 4.5-4.7 (1H, m), 7.4-7.5 
(2H, m), 7.6-7.7 (2H, m), 8.27 (1H, s), 8.31 (1H, s). δc 19.5, 
29.7, 30.2, 31.6, 31.7, 34.8, 36.1, 121.5, 121.9, 128.4,  
129.1, 132.3, 134.1, 164.3, 164.9. m/z (ESI) 571.4 (M-Cl
+
, 
100), 102.1 (77). Found (ESI) 571.3098 (M-Cl
+
 
C33H48N2O3V requires 571.3099).  
4.5.2. [(2S)-[N,N’- bis-(2’-hydroxy-3’,5’-di-tert-butyl 
benzylidene)]-3-phenyl-1,2-diaminopropanato] 
vanadium
V
 chloride 12b. 
 Obtained as a green solid (82%). Mp 130.1-130.6 °C. 
[α]D
20
 -690.0 (c 0.02, CHCl3). υmax 2955 (s), 2869 (m), 
1611 (s) and 1548 cm
-1
 (s). δH 1.22 (9H, s), 1.25 (9H, s), 
1.34 (9H, s), 1.44 (9H, s), 3.0-3.2 (2H, m), 4.0-4.1 (1H, m), 
4.3-4.4 (1H, m), 4.6-4.7 (1H, m), 7.0-7.3 (6H, m), 7.57 
(1H, s), 7.66 (1H, s), 7.78 (1H, s), 8.01 (1H, s), 8.75 (1H, 
s). δc 14.5, 14.7, 24.3, 28.9, 29.4, 31.2, 31.3, 31.4, 31.5, 
34.6, 51.2, 127.2, 127.5, 128.1, 128.5, 128.8, 129.0, 129.3, 
129.6, 129.7, 130.0, 132.1, 132.5, 159.1, 169.7. m/z (ESI) 
647.4 (M-Cl
+
, 100). Found (ESI) 647.3414 (M-Cl
+
 
C39H52N2O3V requires 647.3412).  
4.5.3. [(1R)-[N,N’-bis-(2’-hydroxy-3’,5’-di-tert-butyl 
benzylidene)]-1-phenyl-1,2-diaminoethanato] 
vanadium
V
 chloride 12c. 
 Obtained as a green solid (90%). Mp 163.2-163.4 °C.  
[α]D
20
 +320.0 (c 0.02, CHCl3). υmax 2956 (m), 2921 (s), 
2852 (m), 1614 (s) and 1584 cm
-1
 (m). δH 1.16 (9H, s), 1.18 
(9H, s), 1.33 (9H, s), 1.35 (9H, s), 3.8-3.9 (1H, m),  4.0-4.2 
(1H, m), 4.95 (1H, dd J 8.2, 3.6 Hz), 6.9-7.0 (2H, m), 7.2-
7.5 (5H, m), 7.6-7.7 (2H, m), 8.25 (1H, s), 8.34 (1H, s). δc 
24.6, 28.8, 29.2, 31.4, 31.7, 34.5, 34.8, 51.1, 51.5, 72.7, 
127.5, 128.8, 128.9, 129.0, 129.3, 129.6, 129.7, 129.9, 
130.0, 130.2, 132.1, 132.5, 132.7, 136.2, 144.7, 164.3, 
169.4, 169.8. m/z (ESI) 633.2 (M-Cl
+
, 100), 611.1 (28), 
116.0 (13). Found 633.3254 (M-Cl
+
 C38H50N2O2V requires 
633.3261).  
4.6. [(2S)-[N,N’-bis-(2’-hydroxy-3’,5’-di-tert-butyl 
benzylidene)]-3-methyl-1,2-diaminobutanato] 
vanadium
V
 chloride 12d. 
 Ligand 8d (560 mg, 1.05 mmol) was dissolved in dry 
THF (35 mL) and vanadium
V
 oxychloride (0.15 mL, 1.58 
mmol, 1.5 equiv.) was added with stirring. The solution 
was stirred at room temperature for 30 minutes, then the 
solvent was removed in vacuo. The residue was purified by 
column chromatography on silica gel using first EtOAc / 
hexane (3:1), then EtOAc / hexane / MeOH (1:1:1) as 
eluents. Collection of the dark green fractions and removal 
of the solvent in vacuo gave complex 12d (599 mg, 90%) 
as a green solid. Mp 184.7-184.9 °C. [α]D
20
 -3600.0 (c 
0.0033, CHCl3). υmax 2955 (m), 2869 (m), 1614 (s) and 
1557 cm
-1
 (m). δH 0.88 (3H, d J 6.6 Hz), 1.02 (3H, d J 6.6 
Hz), 1.28 (9H, s), 1.30 (9H, s), 1.43 (9H, s), 1.45 (9H, s), 
2.0-2.1 (1H, m), 3.70 (1H, dd J 9.8, 3.5 Hz), 4.18 (1H, d J 
13.0 Hz), 4.97 (1H, d J 8.0 Hz), 7.4-7.5 (2H, m), 7.6-7.7 
(2H, m), 8.63 (1H, s), 8.72 (1H, s). δc 19.6, 20.0, 20.1, 29.8, 
29.9, 30.1, 30.4, 31.3, 31.7, 34.8, 35.9, 36.1, 63.4, 120.9, 
121.3, 121.8, 128.2, 129.7, 132.2, 132.6, 135.9, 136.5, 
144.5, 162.2, 164.8, 165.7, 166.5. m/z (ESI) 599.3 (M-Cl
+
, 
100). Found 599.3415 (M-Cl
+
 C35H52N2O3V requires 
599.3412).  
4.7. General procedure for the synthesis of 
copper
II
(salen) complexes 13a-d. 
 To a solution of ligand 10a-d (1.0 equiv.) in ethanol / 
water (8:1) was added copper
II
 acetate monohydrate (1.0 
equiv). The mixture was then heated at reflux with vigorous 
stirring for 2 hours, after which the solution was allowed to 
cool to room temperature. The solvent was removed in 
vacuo and Et2O was added to the residue causing a purple 
solid to precipitate. The solid was filtered, washed with 
Et2O and hexane and air dried to give complexes 13a-d. 
4.7.1.  [(2S)-[N,N’-bis-(2’-hydroxybenzylidene)]-1,2-
diaminopropanato] copper
II
 13a. 
 Obtained as a purple solid (60%). Mp 237.6-238.0 °C. 
[α]D
20
 -140.0 (c 0.02, CHCl3). υmax 2970 (m), 2912 (m), 
 Tetrahedron: Asymmetry 12 
1622 (s), 1599 (s), 1536 (s) and 1469 cm
-1
 (m). m.z (EI) 
343.1 (M
+
, 83), 146.0 (100), 132.0 (94), 49.1 (88). Found 
(ESI) 344.0582 (MH
+
 C17H17N2O2Cu requires 344.0581).  
4.7.2. [(2S)-[N,N’-bis-(2’-hydroxybenzylidene)]-3-
phenyl-1,2-diaminopropanato] copper
II
 13b. 
 Obtained as a purple solid (57%). Mp 195.8-196.4 °C 
(decomp.). [α]D
20
 -320.0 (c 0.01, CHCl3). υmax 3024 (w), 
2938 (w), 1621 (s), 1598 (s), 1558 (s), 1495 (m) and 1468 
cm
-1
 (m). m/z (EI) 419.2 (M
+
, 56), 330.1 (43), 328.1 (100), 
132.0 (22). Found (EI) 419.0811 (M
+
 C23H20N2O2Cu 
requires 419.0815).  
4.7.3. [(1R)-[N,N’-bis-(2’-hydroxybenzylidene)]- 1-
phenyl-1,2-diaminoethanato] copper
II
 13c. 
 During the reaction, the product precipitated. The 
reaction mixture was allowed to cool to room temperature, 
and the precipitate filtered and washed with distilled water, 
MeOH and Et2O to afford compound 13c as a purple solid 
(65%). Mp 299.9-300.1 °C. [α]D
20
 -400.0 (c 0.01, CHCl3). 
υmax 3025 (w), 2903 (w), 1626 (s), 1600 (s), 1538 (s), 1506 
(m), 1495 (m) and 1444 cm
-1
 (s). m/z (EI) 405.1 (M
+
,
 
100), 
274.0 (38), 272.0 (91), 208.0 (57), 152.9 (27). Found (EI) 
405.0655 (M
+
 C22H18N2O2Cu requires 405.0659).  
4.7.4. [(2S)-[N,N’-bis-(2’-hydroxybenzylidene)]-3-
methyl-1,2-diaminobutanato] copper
II
 13d. 
 Obtained as a purple solid (42%). Mp 109.8-110.2 °C 
(decomp.). [α]D
20
 -160.0 (c 0.01, CHCl3). υmax 3019 (m), 
2959 (m), 1620 (s), 1599 (s), 1531 (s), 1465 (m), 1443 (m) 
and 1387 cm
-1
 (s). m/z (EI) 371.1 (M
+
, 11), 328.1 (11), 
132.0 (44), 91.1 (27), 77.1 (24), 49.1 (27), 43.2 (100). 
Found (ESI) 372.0892 (MH
+
 C19H23N2O2Cu requires 
372.0894).  
4.8. General procedure for the synthesis of 
cobalt
II
(salen) complexes 14a-c and 15a-d. 
 Ligand 9a-d or 10a-c (1.0 equiv.) and anhydrous cobalt
II
 
acetate (1.0 equiv.) were stirred in dry ethanol at 70 °C for 
one hour under a nitrogen atmosphere. During this time a 
solid precipitated. The mixture was allowed to cool to room 
temperature, filtered and the solid washed with hexane 
under a nitrogen atmosphere. The residue was 
recrystallized from hot ethanol, followed by filtration and 
washing with hexane to give complexes 14a-c and 15a-d. 
4.8.1.  [(2S)-[N,N’-bis-(2’-hydroxybenzylidene)]-1,2-
diaminopropanato] cobalt
II
 14a. 
 Obtained as a chocolate brown solid (42%). Mp 252.8-
253.4 °C. [α]D
20
 -1180.0 (c 0.02, CHCl3). υmax 2913 (m), 
1602 (s), 1591 (s), 1531 (s) and 1469 cm
-1
 (s). m/z (EI) 
339.1 (M
+
, 34), 84.0 (44), 51.1 (44), 49.0 (100). Found 
(ESI) 340.0603 (MH
+
 C17H17N2O2Co requires 340.0617).  
4.8.2. [(2S)-[N,N’-bis-(2’-hydroxybenzylidene)]-3-
phenyl-1,2-diaminopropanato] cobalt
II
 14b. 
 Obtained as an orange / red solid (45%). Mp 279.8-
280.0 °C (decomp.). [α]D
20
 -720.0 (c 0.01, CHCl3). υmax 
3016 (w), 2942 (w), 1599 (s), 1530 (s), 1494 (m), 1469 (m) 
and 1440 cm
-1
 (m). m/z (EI) 415.1 (M
+
, 44), 324.1 (82), 
91.1 (50), 83.9 (55), 49.1 (100). Found (EI) 415.0851 (M
+
 
C23H20N2O2Co requires 415.0851).  
4.8.3. [(1R)-[N,N’-bis-(2’-hydroxybenzylidene)]- 1-
phenyl-1,2-diaminoethanato] cobalt
II
 14c. 
 Obtained as an orange solid (42%). Mp 276.6-277.0 °C 
(decomp.). [α]D
20
 +640.0 (c 0.01, CHCl3). υmax 3028 (w), 
2911 (w), 1603 (s), 1558(m), 1538 (s), 1495 (m), 1447 (m) 
and 1441 cm
-1
 (s). m/z (EI) 401.1 (M
+
, 100), 268.0 (54). 
Found (EI) 401.0697 (M
+
 C22H18N2O2Co requires 
401.0695).  
4.8.4.  [(2S)-[N,N’-bis-(2’-hydroxy-4’-methoxy 
benzylidene)]-1,2-diaminopropanato] cobalt
II
 15a. 
 Obtained as a bright red solid (51%). Mp 239.4-240.0 
°C (decomp.). [α]D
20
 -560.0 (c 0.01, CHCl3). υmax 2961 (m), 
2920 (m), 1588 (s), 1558 (m), 1519 (m), 1485 (m) and 
1217 (s). m/z (EI) 399.2 (M
+
, 19), 235.0 (100), 220.0 (13). 
Found (EI) 399.0755 (M
+
 C19H20N2O4Co requires 
399.0750). 
4.8.5. [(2S)-[N,N’-bis-(2’-hydroxy-4’-methoxybenzyl-
idene)]-3-phenyl-1,2-diaminopropanato] cobalt
II
 15b. 
 Obtained as a bright orange solid (40%). Mp 288.8-
289.0 °C (decomp.). [α]D
20
 -1500.0 (c 0.02, CHCl3). υmax 
2904 (m), 1587 (s), 1519 (s), 1494 (m), 1449 (m) and 1218 
cm
-1
 (s). m/z (EI) 475.2 (M
+
, 93), 384.1 (100). Found (EI) 
475.1065 (M
+
 C25H24N2O4Co requires 475.1063).  
4.8.6. [(1R)-[N,N’-bis-(2’-hydroxy-4’-methoxybenzyl-
idene)]- 1-phenyl-1,2-diaminoethanato] cobalt
II
 15c. 
 Obtained as an orange solid (53%). Mp 295.2-296.6 °C 
(decomp.). [α]D
20
 +440.0 (c 0.01, CHCl3). υmax 3033 (w), 
2999 (w), 2944 (w), 1587 (s), 1531 (m), 1494 (m), 1455 
(m), 1441 (m) and 1210 cm
-1
 (s). m/z (EI) 461.1 (M
+
, 100), 
298.0 (21), 195.0 (10). Found 461.0908 (M
+
 C24H22N2O4Co 
requires 461.0906).  
4.8.7. [(2S)-[N,N’-bis-(2’-hydroxy-4’-methoxybenzyl-
idene)]-3-methyl-1,2-diaminobutanato] cobalt
II
 15d. 
 Obtained as a bright orange solid (64%). Mp 250.6-
251.0 °C (decomp.). [α]D
20
 -160.0 (c 0.01, CHCl3). υmax 
3000 (w), 2989 (w), 2956 (w), 2874 (w), 1607 (s), 1586 
(m), 1519 (s), 1485 (m), 1463 (m) and 1218 cm
-1
 (s). m/z 
(EI) 427.1 (M
+
, 100), 384.1 (75), 162.0 (24), 43.1 (60). 
Found (EI) 427.1066 (M
+
 C21H24N2O4Co requires 
427.1063).  
4.9. [(2S)-[N,N’-bis-(2’-hydroxybenzylidene)]-3-methyl-
1,2-diaminobutanato] cobalt
II
 14d. 
 Ligand 10d (200 mg, 0.64 mmol) and anhydrous cobalt
II
 
acetate (114 mg, 0.64 mmol, 1.0 equiv.) were dissolved in 
dry THF (3 mL) and the reaction mixture was stirred at 60 
°C for 1.5-2 hours under a nitrogen atmosphere. The 
solution was then cooled to room temperature and hexane 
(ca. 10-12 mL) was added until an orange solid 
precipitated. The precipitate was filtered under nitrogen, 
washed with hexane and air dried to give complex 14d as 
an orange solid (206 mg, 87%). Mp 186.2-186.6 °C 
(decomp.). [α]D
20
 -707.7 (c 0.013, CHCl3). υmax 2962 (m), 
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1636 (s), 1600 (s), 1564 (s), 1557 (s), 1530 (s) and 1471 
cm
-1
 (m). m/z (EI) 367.1 (M
+
, 53), 324.2 (36), 176.9 (45), 
131.9 (41), 91.1 (54), 77.1 (54), 58.9 (65), 51.1 (78), 43.2 
(100). Found (EI) 367.0854 (M
+
 C19H22N2O4Co requires 
367.0851). 
4.10. General procedure for the asymmetric synthesis of 
cyanohydrin trimethylsilyl ethers and acetates. 
 The aldehyde (0.984 mmol) and catalyst 11a-d or 12a-d 
(0.1-2.0 mol%) were dissolved in freshly distilled CH2Cl2 
(5 mL). Trimethylsilyl cyanide (0.14 mL, 1.08 mmol, 1.1 
equiv.) was added, and the reaction mixture was left to stir 
at room temperature overnight. The solution was then 
filtered through a pad of silica gel using CH2Cl2 as eluent. 
The solvent was removed in vacuo to leave the 
cyanohydrin trimethylsilyl ether as a yellow oil which was 
analyzed by 
1
H NMR spectroscopy without further 
purification to determine the conversion. A sample of the 
cyanohydrin trimethylsilyl ether and scandium triflate (1 
mol%) were dissolved in acetonitrile (5 mL), and Ac2O 
(2.0 equiv.) was added. The reaction mixture was stirred at 
room temperature for 20 minutes, before being filtered 
through a pad of silica using CH2Cl2 as eluent. Removal of 
the solvent in vacuo gave the cyanohydrin acetate (100% 
conversion) which was analyzed by chiral GC. 
4.10.1. Phenyl-trimethylsilanoxy-acetonitrile 16.2c 
 Obtained as a yellow oil (up to 100% conversion, and up 
to 81% ee). δH 0.23 (9H, s), 5.48 (1H, s), 7.1-7.3 (5H, m). 
GC conditions: Initial temperature 100 °C, hold for 2 
minutes, ramp rate 5 °C / minute. tR R enantiomer 15.7 
minutes, tR S enantiomer 16.0 minutes. 
4.10.2. (S)-(2-Methylphenyl)-trimethylsilanoxy-
acetonitrile.
2c
 
 Obtained as a yellow oil (93% conversion, 66% ee). δH 
0.14 (9H, s), 2.47 (3H, s), 5.61 (1H, s), 7.2-7.4 (4H, m). GC 
conditions: Initial temperature 100 °C, hold for 5 minutes, 
ramp rate 1 °C / minute. tR R enantiomer 35.4 minutes, tR S 
enantiomer 35.7 minutes. 
4.10.3.  (S)-(3-Methylphenyl)-trimethylsilanoxy-
acetonitrile.
2c
 
 Obtained as a yellow oil (86% conversion, 81% ee). δH 
0.24 (9H, s), 2.39 (3H, s), 5.46 (1H, s), 7.0-7.3 (4H, m). GC 
conditions: Initial temperature 100 °C, hold for 5 minutes, 
ramp rate 3 °C / minute. tR R enantiomer 29.7 minutes, tR S 
enantiomer 30.0 minutes. 
4.10.4.  (S)-(4-Methylphenyl)-trimethylsilanoxy-
acetonitrile.
2c
 
 Obtained as a yellow oil (90% conversion, 78% ee). δH 
0.22 (9H, s), 2.37 (3H, s), 5.45 (1H, s), 7.0-7.2 (4H, m). GC 
conditions: Initial temperature 100 °C, hold for 5 minutes, 
ramp rate 5° C / minutes. tR R enantiomer 29.7 minutes, tR S 
enantiomer 30.0 minutes. 
4.10.5.  (S)-(3-Methoxyphenyl)-trimethylsilanoxy-
acetonitrile.
2a
 
 Obtained as a yellow oil (98% conversion, 66% ee). δH 
0.24 (9H, s), 3.85 (3H, s), 5.50 (1H, s), 6.9-7.4 (4H, m). GC 
conditions: Initial temperature 120 °C, hold for 5 minutes, 
ramp rate 20 °C / minute. tR R enantiomer 10.9 minutes, tR 
S enantiomer 11.1 minutes. 
4.10.6.  (S)-(4-Methoxyphenyl)-trimethylsilanoxy-
acetonitrile.
2c
 
 Obtained as a yellow oil (100% conversion, 45% ee). δH 
0.04 (9H, s), 3.65 (3H, s), 5.23 (1H, s), 6.7-6.8 (2H, m), 
7.1-7.2 (2H, m). GC conditions: Initial temperature 100 °C, 
hold for 5 minutes, ramp rate 2 °C / minute, final 
temperature 180 °C, hold for 5 minutes. tR R enantiomer 
42.9 minutes, tR S enantiomer 43.3 minutes. 
4.10.7. (S)-(4-Trifluoromethylphenyl)-
trimethylsilanoxy-acetonitrile.
2a
 
 Obtained as a yellow oil (100% conversion, 77% ee). δH 
0.27 (9H, s), 5.55 (1H, s), 6.7-6.8 (2H, m), 7.1-7.2 (2H, m). 
GC conditions: Initial temperature 100 °C, hold for 5 
minutes, ramp rate 5 °C / minute. tR R enantiomer 17.3 
minutes, tR S enantiomer 17.7 minutes. 
4.10.8.  (S)-2-Trimethylsilanoxy-deconitrile.31 
 Obtained as a yellow oil (93% conversion, 73% ee). δH 
0.21 (9H, s), 0.86 (3H, t J 6.7 Hz), 1.0-1.1 (10H, m), 1.2-
1.3 (2H, m), 1.5-1.6 (2H, m), 4.41 (1H, t J 6.6 Hz). GC 
conditions: Initial temperature 100 °C, hold for 5 minutes, 
ramp rate 5 °C / minute. tR R enantiomer 19.6 minutes, tR S 
enantiomer 19.8 minutes. 
4.10.9.  (S)-2-Trimethylsilanoxy-3-methyl-
butanonitrile.
2a
 
 Obtained as a yellow oil (85% conversion, 73% ee). δH 
0.21 (9H, s), 1.01 (3H, d J 6.8 Hz), 1.02 (3H, d J 6.7 Hz), 
1.7-1.8 (1H, m), 4.15 (1H, d J 5.9 Hz). GC conditions: 
Initial temperature 100 °C, hold for 5 minutes, ramp rate 5 
°C / minute. tR R enantiomer 4.5 minutes, tR S enantiomer 
4.8 minutes. 
4.10.10. (S)-Cyclohexyl-trimethylsilanoxy-acetonitrile.32 
 Obtained as a yellow oil (91% conversion, 73% ee). δH 
0.21 (9H, s), 0.8-1.1 (6H, m), 1.4-1.7 (5H, m), 4.14 (1H, d 
J 6.3 Hz). GC conditions: Initial temperature 100 °C, hold 
for 5 minutes, ramp rate 5 °C / minute. tR R enantiomer 
17.3 minutes, tR S enantiomer 17.6 minutes. 
4.10.11.  (S)-2-Trimethylsilanoxy-3,3-dimethyl-
butanonitrile.
2c
 
 Obtained as a yellow oil (100% conversion, 45% ee). δH 
0.21 (9H, s), 1.01 (9H, s), 3.99 (1H, s). GC conditions: 
Initial temperature 100 °C, hold for 5 minutes, ramp rate 5 
°C / minute. tR R enantiomer 5.0 minutes, tR S enantiomer 
5.3 minutes. 
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4.11. General procedure for the asymmetric synthesis of 
amino nitrile 19. 
 Vanadium
V
(salen) complex 12a-d (0.05 mmol, 10 
mol%) was dissolved in toluene (20 mL) under an argon 
atmosphere and the solution was cooled to -40 °C. 
Trimethylsilyl cyanide (0.075 mL, 0.58 mmol, 1.2 equiv.) 
and methanol (0.03 mL, 0.58 mmol, 1.2 equiv.) were added 
and the reaction mixture was stirred at -40 °C for one hour. 
Imine 18 (0.085 mL, 0.48 mmol, 1.0 equiv.) was then 
added and the reaction stirred at -40 °C for 24 hours. The 
reaction mixture was filtered through a pad of silica using 
CH2Cl2 as eluent and the solvent was removed in vacuo to 
give aminonitrile 19 as a yellow oil (100% conversion, 
≤90% ee). δH 4.04 (1H, d J 13.0 Hz), 4.15 (1H, d J 13.0 
Hz), 4.84 (1H, broad s), 4.96 (1H, s), 7.3-7.4 (6H, m), 7.4-
7.5 (4H, m). The enantiomeric excess of the product was 
determined by with reaction of amino nitrile 19 with (R)-
camphor sulphonic acid in an NMR tube. The 
distereomeric excess of the two diastereomers, and hence 
the enantiomeric excess of amino nitrile 19, was then 
determined using 
1
H-NMR spectroscopy. 
4.12. General procedure for the asymmetric synthesis of 
-methyl phenylalanine 21. 
 (±)-4-(Chlorobenzylidene)alanine methyl ester 20 (0.237 
g, 1.05 mmol), complex 13a-d or 14a-d (2 mol%, 0.02 
mmol), and powdered sodium hydroxide (excess) were 
added to dry toluene (2.5 mL). Benzyl bromide (0.15 mL, 
1.26 mmol, 1.2 equiv.) was added and the reaction mixture 
was stirred at room temperature overnight under an argon 
atmosphere. Methanol (2 mL) and acetyl chloride (0.5 mL) 
were then slowly added to the reaction and the mixture was 
left to stir for another four hours. The solvents were then 
removed in vacuo, and the residue purified by column 
chromatography on silica gel using first EtOAc (300 mL), 
followed by EtOAc / EtOH (4:1) as eluent to give amino 
ester 21. δH 1.32 (3H, s), 1.54 (2H, broad s), 2.71 (1H, d J 
13.2 Hz), 3.04 (1H, d J 13.2 Hz), 3.63 (3H, s), 7.0-7.3 (5H, 
m). δc 28.3, 48.6, 53.7, 60.5, 128.6, 129.0, 131.6, 138.2, 
179.2. The enantiomeric excess of compound 21 was 
determined by reaction with (S)-1-phenylethyl isocyanate 
in an NMR tube. The diastereomeric excess of the resulting 
diastereomers, and hence the enantiomeric excess of amino 
ester 21, could then be determined by 
1
H-NMR 
spectroscopy. 
4.13. General procedure for asymmetric Darzens 
condensations. 
 N,N-Diphenyl-2-halo-acetamide 23 or 24 (0.569 mmol, 
1.2 equiv.), potassium hydroxide (63 mg, 1.139 mmol, 2.4 
equiv.) and complex 15a-d (2 mol%) were dissolved in 
CH2Cl2 (4 mL) and benzaldehyde (50 mg, 0.474 mmol, 1.0 
equiv.) was added. The reaction mixture was stirred at 
room temperature for 4 hours, and then quenched with 1M 
hydrochloric acid (1 mL). The organic layer was separated 
and the aqueous layer was extracted with EtOAc (3 x 2 
mL). The combined organic phases were washed with 
saturated sodium chloride solution (6 mL), dried (Na2SO4), 
filtered and the solvent removed in vacuo. At this stage the 
product was analyzed by 
1
H NMR spectroscopy to 
determine the cis / trans ratio. The product was then 
purified by column chromatography on silica gel using 
hexane / EtOAc (3:1) to give a mixture of cis 25 and trans 
26 isomers of product as a yellow oil. HPLC tR cis 10.3 and 
12.5 minutes; tR trans 17.6 and 25.0 minutes. υmax 3063 
(m), 3038 (m), 1689 (s), 1594 (s) and 1492 cm
-1
 (s). δH(cis) 
3.68 (1H, d J 4.6 Hz), 3.79 (1H, d J 4.6 Hz), 6.8-7.5 (15H, 
m). δH(trans) 3.24 (1H, d J 1.8 Hz), 4.11 (1H, d J 1.8 Hz), 
7.1-7.5 (15H, m). δc(cis) 59.1, 59.4, 126.2, 127.4, 128.3, 
128.5, 128.9, 129.6, 129.8, 130.3, 134.2, 135.9, 141.9, 
142.2, 165.1. δc(trans) 58.2, 59.0, 126.2, 127.6, 128.3, 
128.5, 128.8, 129.6, 129.8, 130.3, 134.2, 135.9, 141.9, 
142.2, 166.8. Found (ESI) 316.1338 (MH
+
 C21H18NO2 
requires 316.1338). 
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